Stryker Corporation (SYK)
Portage, MI, US
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
4 articles
- Stryker: Medtech On Sale, Benefiting From Industry Growth Seeking Alpha
- ICUI vs. SYK: Which Stock Should Value Investors Buy Now? Zacks Investment Research
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| Colorado | IGTI | 2000-06-28 | View |
Index membership
| Index | Added | Removed | Status |
|---|---|---|---|
| S&P 500 | 2000-12-11 | — | Active |
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.20% | +0.15% | -15.20% | -19.56% | -21.15% | -16.22% | -24.02% | +1.91% | +18.80% | +165.49% | +353,232.93% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 8 | 0 |
| Buy | 14 | 0 |
| Hold | 7 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 9 |
371.89
+13.9%
|
| Last Quarter | 11 |
382.91
+17.3%
|
| Last Year | 29 |
406.76
+24.6%
|
| All Time | 80 |
354.78
+8.6%
|
-
Revenue growth Medical - Devices: +11.2%+11.2% Q1'26: +2.6% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%+8.3% Q1'26: +14.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%+13.2% Q1'26: +6.9% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%+20.4% ★ Q1'26: +15.5% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%+11.1% ★ Q1'26: +9.8% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%-0.9% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×2.35× Q1'26: 2.88× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 19 Rev. Ana. 16 EPS Ana. |
Dec 2027 20 Rev. Ana. 17 EPS Ana. |
Dec 2028 18 Rev. Ana. 7 EPS Ana. |
Dec 2029 11 Rev. Ana. 2 EPS Ana. |
Dec 2030 9 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8.31B
est: 8.24B (+0.8%)
|
8.66B
est: 8.66B (0.0%)
|
9.02B
est: 9.05B (-0.3%)
|
9.68B
est: 9.72B (-0.4%)
|
9.95B
est: 9.94B (+0.0%)
|
11.33B
est: 11.32B (+0.1%)
|
12.44B
est: 12.39B (+0.5%)
|
13.60B
est: 13.54B (+0.4%)
|
14.88B
est: 14.86B (+0.2%)
|
14.35B
est: 14.42B (-0.5%)
|
17.11B
est: 17.06B (+0.3%)
|
18.45B
est: 18.21B (+1.3%)
|
20.50B
est: 21.39B (-4.2%)
|
22.60B
est: 22.52B (+0.3%)
|
25.12B
est: 25.07B (+0.2%)
|
27.28B
27.15B – 27.37B
+8.8% YoY
|
29.61B
29.12B – 30.13B
+8.6% YoY
|
32.02B
31.99B – 32.05B
+8.1% YoY
|
35.00B
34.61B – 35.39B
+9.3% YoY
|
37.95B
37.53B – 38.38B
+8.4% YoY
|
| EBITDA |
2.26B
est: 2.17B (+4.4%)
|
2.05B
est: 1.90B (+7.7%)
|
1.61B
est: 1.52B (+6.3%)
|
1.65B
est: 1.54B (+7.1%)
|
2.24B
est: 2.09B (+7.0%)
|
2.70B
est: 2.42B (+11.3%)
|
2.95B
est: 2.66B (+10.9%)
|
3.34B
est: 3.01B (+10.9%)
|
3.63B
est: 3.29B (+10.2%)
|
3.08B
est: 2.13B (+44.8%)
|
3.61B
est: 3.26B (+10.5%)
|
4.02B
est: 3.48B (+15.3%)
|
5.06B
est: 4.90B (+3.2%)
|
4.94B
est: 5.16B (-4.3%)
|
6.31B
est: 5.74B (+10.0%)
|
6.25B
6.22B – 6.27B
+8.8% YoY
|
6.78B
6.67B – 6.90B
+8.6% YoY
|
7.33B
7.33B – 7.34B
+8.1% YoY
|
8.02B
7.93B – 8.11B
+9.3% YoY
|
8.69B
8.60B – 8.79B
+8.4% YoY
|
| EBIT |
1.78B
est: 1.67B (+6.5%)
|
1.77B
est: 1.74B (+1.6%)
|
1.31B
est: 1.25B (+4.2%)
|
1.27B
est: 1.25B (+2.0%)
|
1.84B
est: 1.83B (+0.8%)
|
2.15B
est: 2.13B (+1.0%)
|
2.31B
est: 2.25B (+2.5%)
|
2.62B
est: 2.48B (+5.5%)
|
2.85B
est: 2.67B (+6.5%)
|
2.27B
est: 1.69B (+34.2%)
|
2.62B
est: 2.58B (+1.6%)
|
3.02B
est: 2.76B (+9.6%)
|
4.03B
est: 3.80B (+5.9%)
|
3.89B
est: 4.01B (-2.9%)
|
5.12B
est: 4.46B (+14.9%)
|
4.85B
4.83B – 4.87B
+8.8% YoY
|
5.27B
5.18B – 5.36B
+8.6% YoY
|
5.69B
5.69B – 5.70B
+8.1% YoY
|
6.22B
6.16B – 6.29B
+9.3% YoY
|
6.75B
6.68B – 6.83B
+8.4% YoY
|
| Net Income |
1.35B
est: 1.33B (+0.8%)
|
1.30B
est: 1.30B (-0.2%)
|
1.01B
est: 1.00B (+0.2%)
|
515.00M
est: 517.59M (-0.5%)
|
1.44B
est: 1.41B (+1.7%)
|
1.65B
est: 1.62B (+1.9%)
|
1.02B
est: 994.79M (+2.5%)
|
3.55B
est: 3.49B (+1.8%)
|
2.08B
est: 2.05B (+1.5%)
|
1.60B
est: 1.22B (+31.1%)
|
1.99B
est: 1.98B (+0.5%)
|
2.36B
est: 2.16B (+9.1%)
|
3.17B
est: 3.45B (-8.2%)
|
2.99B
est: 4.61B (-35.1%)
|
3.25B
est: 5.18B (-37.4%)
|
5.72B
5.68B – 5.76B
+10.4% YoY
|
6.25B
5.92B – 6.58B
+9.2% YoY
|
7.18B
6.61B – 7.75B
+15.0% YoY
|
8.09B
7.97B – 8.21B
+12.6% YoY
|
8.91B
8.78B – 9.04B
+10.1% YoY
|
| SGA |
3.08B
est: 3.12B (-1.3%)
|
3.39B
est: 3.46B (-2.2%)
|
3.31B
est: 4.08B (-18.9%)
|
3.38B
est: 3.59B (-5.9%)
|
3.51B
est: 3.54B (-0.9%)
|
3.95B
est: 4.06B (-2.7%)
|
4.35B
est: 4.48B (-2.9%)
|
4.63B
est: 4.99B (-7.1%)
|
5.02B
est: 5.28B (-4.8%)
|
4.82B
est: 4.30B (+12.1%)
|
5.81B
est: 6.44B (-9.8%)
|
6.08B
est: 7.00B (-13.2%)
|
6.92B
est: 7.20B (-3.9%)
|
7.51B
est: 7.58B (-1.0%)
|
8.65B
est: 8.44B (+2.5%)
|
9.18B
9.14B – 9.21B
+8.8% YoY
|
9.97B
9.80B – 10.14B
+8.6% YoY
|
10.78B
10.77B – 10.79B
+8.1% YoY
|
11.78B
11.65B – 11.92B
+9.3% YoY
|
12.78B
12.64B – 12.92B
+8.4% YoY
|
| EPS |
3.48
est: 3.67 (-5.2%)
|
3.41
est: 4.08 (-16.4%)
|
2.66
est: 4.26 (-37.6%)
|
1.36
est: 4.77 (-71.5%)
|
3.82
est: 5.11 (-25.2%)
|
4.40
est: 5.78 (-23.9%)
|
2.73
est: 6.48 (-57.9%)
|
9.50
est: 7.28 (+30.5%)
|
5.57
est: 8.23 (-32.3%)
|
4.26
est: 7.18 (-40.7%)
|
5.29
est: 9.11 (-41.9%)
|
6.23
est: 9.18 (-32.1%)
|
8.34
est: 9.07 (-8.0%)
|
7.86
est: 12.05 (-34.8%)
|
8.49
est: 13.56 (-37.4%)
|
14.98
14.86 – 15.08
+10.4% YoY
|
16.75
15.48 – 17.22
+11.8% YoY
|
18.69
17.31 – 20.29
+11.6% YoY
|
21.16
20.86 – 21.47
+13.2% YoY
|
23.31
22.97 – 23.65
+10.1% YoY
|
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-04 | Barclays | Overweight | Overweight | Maintain |
| 2026-05-01 | Evercore ISI Group | Outperform | Outperform | Maintain |
| 2026-04-15 | Truist Securities | Hold | Hold | Maintain |
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-01 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Stryker Corporation | 30.03M | 100.00% | 30.03M | — | 30.03M | 10.00 | CO | Michigan | 2018-02-28 | ↗ |
| 2 | The Vanguard Group - 23-1945930 | 28.65M | 7.60% | — | 552.7K | 27.27M | 1.39M | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 3 | (1) BlackRock, Inc. | 23.86M | 6.30% | 21.03M | — | 23.86M | — | HC | Delaware | 2022-02-07 | ↗ |
| 4 | 52-0556948 | 21.16M | 5.50% | 8.86M | — | 21.16M | — | IA | Maryland | 2022-02-14 | ↗ |
| 5 | 38-3416104 | 20.45M | 5.40% | 114.3K | 20.34M | 110.1K | 20.34M | BK | State of Michigan | 2022-02-11 | ↗ |
| 6 | John W. Brown | 20.06M | 5.30% | 19.80M | 260.0K | 19.80M | 260.0K | IN | U.S. | 2021-02-09 | ↗ |
| 7 | Jon L. Stryker | 18.57M | 4.70% | 3.21M | 15.35M | 3.21M | — | IN | U.S. | 2011-01-27 | ↗ |
| 8 | First Western Trust Bank 27-0083757 | 17.14M | 4.51% | 48.5K | 17.09M | 48.5K | — | BK | U.S. | 2012-02-22 | ↗ |
| 9 | Capital Research Global Investors ** | 13.84M | 3.60% | 13.84M | — | 13.84M | — | IA | Delaware | 2019-02-14 | ↗ |
| 10 | Owl Acquisition Corporation | 10.23M | 13.28% | — | 10.23M | — | 10.00 | CO | Delaware | 2011-05-26 | ↗ |
| 11 | Tax I.D. # - 98-0201080 | 8.75M | 4.47% | 8.75M | — | 8.75M | — | IA | Hamilton, Bermuda | 2001-02-26 | ↗ |
| 12 | Edward C. Johnson 3d | 4.16M | 4.29% | — | — | 4.16M | — | IN | United States of America | 2000-02-14 | ↗ |
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 33.91M +133.9K (+0.4%) | 11.92B -567.6M (-4.5%) | 8.87% +0.035 pp | 0.17% -0.014 pp | USD167.61 +109.7% | 84 qtrs — |
| 2 | BLACKROCK, INC. | 27.45M +720.6K (+2.7%) | 9.65B -233.2M (-2.4%) | 7.18% +0.189 pp | 0.16% -0.010 pp | USD361.18 -2.7% | 6 qtrs — |
| 3 | GREENLEAF TRUST | 16.56M -79.3K (-0.5%) | 5.82B -330.8M (-5.4%) | 4.33% -0.021 pp | 53.36% -2.570 pp | USD69.89 +402.9% | 51 qtrs — |
| 4 | STATE STREET CORP | 15.25M +311.5K (+2.1%) | 5.37B -161.5M (-2.9%) | 3.99% +0.082 pp | 0.18% -0.012 pp | USD127.85 +174.9% | 51 qtrs — |
| 5 | JPMORGAN CHASE & CO | 12.15M +205.0K (+1.7%) | 4.27B -145.3M (-3.3%) | 3.18% +0.054 pp | 0.27% +0.004 pp | USD311.90 +12.7% | 51 qtrs — |
| 6 | PRICE T ROWE ASSOCIATES INC /MD/ | 10.12M -879.9K (-8.0%) | 3.56B -509.4M (-12.5%) | 2.65% -0.230 pp | 0.38% -0.052 pp | USD157.39 +123.3% | 75 qtrs — |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 7.54M +69.9K (+0.9%) | 2.64B -110.1M (-4.0%) | 1.97% +0.018 pp | 0.16% -0.013 pp | USD184.77 +90.2% | 78 qtrs — |
| 8 | WELLINGTON MANAGEMENT GROUP LLP | 6.49M +1.2M (+22.6%) | 2.28B +324.9M (+16.6%) | 1.70% +0.314 pp | 0.40% +0.057 pp | USD263.44 +33.4% | 65 qtrs — |
| 9 | ALLIANCEBERNSTEIN L.P. | 6.44M +106.3K (+1.7%) | 2.26B -78.0M (-3.3%) | 1.69% +0.028 pp | 0.72% -0.023 pp | USD368.47 -4.6% | 61 qtrs — |
| 10 | MORGAN STANLEY | 6.25M -207.0K (-3.2%) | 2.20B -190.3M (-8.0%) | 1.64% -0.054 pp | 0.13% -0.013 pp | USD236.23 +48.8% | 51 qtrs — |
| 11 | CAPITAL RESEARCH GLOBAL INVESTORS | 5.97M -307.7K (-4.9%) | 2.10B -222.4M (-9.6%) | 1.56% -0.081 pp | 0.39% -0.048 pp | USD167.78 +109.5% | 51 qtrs — |
| 12 | NORGES BANK | 5.18M +5.2M (+100.0%) | 1.82B +1.8B (+100.0%) | 1.36% +1.357 pp | 0.19% +0.195 pp | USD351.47 +0.0% | 1 qtrs NEW |
| 13 | BANK OF AMERICA CORP /DE/ | 4.42M +536.4K (+13.8%) | 1.56B +117.8M (+8.2%) | 1.16% +0.140 pp | 0.11% +0.016 pp | USD291.64 +20.5% | 52 qtrs — |
| 14 | BANK OF NEW YORK MELLON CORP | 4.31M -225.5K (-5.0%) | 1.52B -161.8M (-9.6%) | 1.13% -0.059 pp | 0.27% -0.056 pp | USD76.19 +361.3% | 66 qtrs — |
| 15 | FUNDSMITH LLP | 3.69M -903.8K (-19.7%) | 1.30B -401.2M (-23.6%) | 0.96% -0.237 pp | 7.57% -1.002 pp | USD132.09 +166.1% | 52 qtrs — |
| 16 | NORTHERN TRUST CORP | 3.35M -76.3K (-2.2%) | 1.18B -89.1M (-7.0%) | 0.88% -0.020 pp | 0.15% -0.012 pp | USD121.71 +188.8% | 51 qtrs — |
| 17 | FIRST WESTERN TRUST BANK | 3.25M -380.0 (0.0%) | 1.14B -59.3M (-4.9%) | 0.85% 0.000 pp | 56.21% +0.981 pp | USD267.34 +31.5% | 16 qtrs — |
| 18 | FRANKLIN RESOURCES INC | 3.20M -93.2K (-2.8%) | 1.12B -92.7M (-7.6%) | 0.84% -0.024 pp | 0.28% -0.028 pp | USD86.33 +307.1% | 51 qtrs — |
| 19 | FISHER ASSET MANAGEMENT, LLC | 3.12M -192.8K (-5.8%) | 1.10B -128.0M (-10.5%) | 0.82% -0.051 pp | 0.37% -0.069 pp | USD213.84 +64.4% | 33 qtrs — |
| 20 | ROYAL BANK OF CANADA | 3.07M -268.5K (-8.0%) | 1.08B -155.2M (-12.6%) | 0.80% -0.070 pp | 0.18% -0.027 pp | USD294.24 +19.5% | 51 qtrs — |
| 21 | FMR LLC | 2.98M -2.2M (-42.1%) | 1.05B -854.0M (-44.9%) | 0.78% -0.566 pp | 0.05% -0.046 pp | USD280.57 +25.3% | 70 qtrs — |
| 22 | LEGAL & GENERAL GROUP PLC | 2.37M +62.8K (+2.7%) | 831.62M -19.8M (-2.3%) | 0.62% +0.016 pp | 0.18% -0.007 pp | USD165.13 +112.8% | 75 qtrs — |
| 23 | WELLS FARGO & COMPANY/MN | 2.26M -30.9K (-1.4%) | 792.97M -52.5M (-6.2%) | 0.59% -0.008 pp | 0.14% -0.016 pp | USD150.08 +134.2% | 57 qtrs — |
| 24 | GOLDMAN SACHS GROUP INC | 2.15M -295.4K (-12.1%) | 755.62M -148.3M (-16.4%) | 0.56% -0.077 pp | 0.09% -0.018 pp | USD263.31 +33.5% | 73 qtrs — |
| 25 | JANUS HENDERSON GROUP PLC | 2.08M +444.6K (+27.3%) | 729.42M +126.6M (+21.0%) | 0.54% +0.116 pp | 0.33% +0.051 pp | USD265.76 +32.3% | 88 qtrs — |
| 26 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.07M +30.2K (+1.5%) | 729.16M -26.6M (-3.5%) | 0.54% +0.008 pp | 0.11% -0.007 pp | USD172.84 +103.3% | 100 qtrs — |
| 27 | PARNASSUS INVESTMENTS, LLC | 1.95M +366.1K (+23.1%) | 684.51M +99.9M (+17.1%) | 0.51% +0.096 pp | 1.78% +0.424 pp | USD359.42 -2.2% | 6 qtrs — |
| 28 | UBS ASSET MANAGEMENT AMERICAS INC | 1.87M +27.4K (+1.5%) | 656.41M -23.9M (-3.5%) | 0.49% +0.007 pp | 0.14% -0.009 pp | USD242.51 +44.9% | 90 qtrs — |
| 29 | CLEARBRIDGE INVESTMENTS, LLC | 1.70M -105.9K (-5.9%) | 597.98M -70.1M (-10.5%) | 0.45% -0.028 pp | 0.48% -0.024 pp | USD218.46 +60.9% | 62 qtrs — |
| 30 | INVESCO LTD. | 1.68M -180.8K (-9.7%) | 591.91M -97.5M (-14.1%) | 0.44% -0.047 pp | 0.09% -0.018 pp | USD240.62 +46.1% | 57 qtrs — |
| 31 | NUVEEN, LLC | 1.57M +44.9K (+2.9%) | 550.91M -11.9M (-2.1%) | 0.41% +0.012 pp | 0.14% -0.004 pp | USD371.61 -5.4% | 4 qtrs — |
| 32 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 1.49M +216.6K (+17.0%) | 524.52M +53.5M (+11.4%) | 0.39% +0.057 pp | 0.43% +0.044 pp | USD265.27 +32.5% | 99 qtrs — |
| 33 | UBS GROUP AG | 1.47M +66.4K (+4.7%) | 517.35M -2.3M (-0.4%) | 0.39% +0.017 pp | 0.08% +0.003 pp | USD297.17 +18.3% | 45 qtrs — |
| 34 | SCHRODER INVESTMENT MANAGEMENT GROUP | 1.43M -77.5K (-5.2%) | 501.11M -54.6M (-9.8%) | 0.37% -0.020 pp | 0.38% -0.051 pp | USD309.56 +13.5% | 51 qtrs — |
| 35 | AMERIPRISE FINANCIAL INC | 1.34M +30.2K (+2.3%) | 472.33M -11.7M (-2.4%) | 0.35% +0.008 pp | 0.11% -0.004 pp | USD227.69 +54.4% | 55 qtrs — |
| 36 | FUNDSMITH INVESTMENT SERVICES LTD. | 1.31M -246.4K (-15.9%) | 459.51M -114.9M (-20.0%) | 0.34% -0.065 pp | 8.41% -0.545 pp | USD269.90 +30.2% | 19 qtrs — |
| 37 | WINSLOW CAPITAL MANAGEMENT, LLC | 1.30M +356.8K (+37.9%) | 458.56M +110.1M (+31.6%) | 0.34% +0.093 pp | 1.54% +0.388 pp | USD358.57 -2.0% | 6 qtrs — |
| 38 | DIMENSIONAL FUND ADVISORS LP | 1.26M +327.5K (+35.1%) | 443.11M +98.2M (+28.5%) | 0.33% +0.086 pp | 0.09% +0.019 pp | USD226.30 +55.3% | 51 qtrs — |
| 39 | BARCLAYS PLC | 1.17M +166.7K (+16.6%) | 410.75M +48.8M (+13.5%) | 0.31% +0.044 pp | 0.10% +0.006 pp | USD319.98 +9.8% | 51 qtrs — |
| 40 | LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | 1.15M -4.2K (-0.4%) | 409.09M -34.5M (-7.8%) | 0.30% -0.001 pp | 3.71% -0.185 pp | USD62.24 +464.7% | 83 qtrs — |
| 41 | DEUTSCHE BANK AG\ | 1.16M +43.4K (+3.9%) | 407.39M -5.1M (-1.2%) | 0.30% +0.011 pp | 0.13% -0.006 pp | USD266.47 +31.9% | 50 qtrs — |
| 42 | NORDEA INVESTMENT MANAGEMENT AB | 1.10M -6.1K (-0.6%) | 386.71M -19.2M (-4.7%) | 0.29% -0.002 pp | 0.33% -0.023 pp | USD278.43 +26.2% | 85 qtrs — |
| 43 | AMERICAN CENTURY COMPANIES INC | 1.01M +94.4K (+10.3%) | 356.47M +16.4M (+4.8%) | 0.27% +0.025 pp | 0.18% +0.006 pp | USD334.62 +5.0% | 29 qtrs — |
| 44 | PNC FINANCIAL SERVICES GROUP, INC. | 997.5K -32.6K (-3.2%) | 350.58M -30.2M (-7.9%) | 0.26% -0.009 pp | 0.19% -0.040 pp | USD130.05 +170.3% | 51 qtrs — |
| 45 | RAYMOND JAMES FINANCIAL INC | 986.7K +33.8K (+3.6%) | 346.83M -5.4M (-1.5%) | 0.26% +0.009 pp | 0.11% -0.005 pp | USD359.78 -2.3% | 5 qtrs — |
| 46 | CI PRIVATE WEALTH, LLC | 981.4K +31.4K (+3.3%) | 345.02M -6.2M (-1.8%) | 0.26% +0.008 pp | 0.46% -0.089 pp | USD273.72 +28.4% | 13 qtrs — |
| 47 | AMUNDI | 974.2K -7.5K (-0.8%) | 342.42M -17.2M (-4.8%) | 0.25% -0.002 pp | 0.09% -0.023 pp | USD309.91 +13.4% | 19 qtrs — |
| 48 | BLUESPRUCE INVESTMENTS, LP | 943.6K +62.9K (+7.1%) | 331.66M +6.1M (+1.9%) | 0.25% +0.016 pp | 8.46% +0.987 pp | USD361.47 -2.8% | 7 qtrs — |
| 49 | SWISS NATIONAL BANK | 942.9K -48.6K (-4.9%) | 331.39M -35.1M (-9.6%) | 0.25% -0.013 pp | 0.20% -0.015 pp | USD158.89 +121.2% | 51 qtrs — |
| 50 | BNP PARIBAS ARBITRAGE, SNC | 913.2K +187.7K (+25.9%) | 320.95M +52.8M (+19.7%) | 0.24% +0.049 pp | 0.15% +0.002 pp | USD323.94 +8.5% | 51 qtrs — |
| 51 | CIBC PRIVATE WEALTH GROUP, LLC | 853.9K -29.0K (-3.3%) | 300.11M -26.2M (-8.0%) | 0.22% -0.008 pp | 0.51% -0.051 pp | USD188.56 +86.4% | 48 qtrs — |
| 52 | 1832 ASSET MANAGEMENT L.P. | 845.6K +608.1K (+256.1%) | 297.19M +209.4M (+238.6%) | 0.22% +0.159 pp | 0.23% +0.157 pp | USD346.86 +1.3% | 31 qtrs — |
| 53 | BLAIR WILLIAM & CO/IL | 844.9K -74.6K (-8.1%) | 296.96M -43.0M (-12.6%) | 0.22% -0.020 pp | 0.80% -0.108 pp | USD168.96 +108.0% | 51 qtrs — |
| 54 | MACKENZIE FINANCIAL CORP | 820.0K -423.6K (-34.1%) | 289.81M -169.9M (-37.0%) | 0.21% -0.111 pp | 0.34% -0.214 pp | USD324.86 +8.2% | 40 qtrs — |
| 55 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 815.0K +20.0K (+2.5%) | 286.44M -7.4M (-2.5%) | 0.21% +0.005 pp | 0.17% -0.001 pp | USD155.52 +126.0% | 59 qtrs — |
| 56 | BANK JULIUS BAER & CO. LTD, ZURICH | 807.5K +34.8K (+4.5%) | 284.14M -1.5M (-0.5%) | 0.21% +0.009 pp | 0.78% -0.021 pp | USD351.13 +0.1% | 24 qtrs — |
| 57 | DEKABANK DEUTSCHE GIROZENTRALE | 752.7K +— (+0.0%) | 279.57M +2.7M (+1.0%) | 0.20% +0.000 pp | 0.48% +0.017 pp | USD245.68 +43.1% | 66 qtrs — |
| 58 | APG ASSET MANAGEMENT N.V. | 931.0K -12.6K (-1.3%) | 278.62M -18.3M (-6.2%) | 0.24% -0.003 pp | 0.79% -0.043 pp | USD368.36 -4.6% | 51 qtrs — |
| 59 | JENSEN INVESTMENT MANAGEMENT INC | 731.5K -488.5K (-40.0%) | 257.12M -193.9M (-43.0%) | 0.19% -0.128 pp | 4.05% -1.551 pp | USD155.82 +125.6% | 51 qtrs — |
| 60 | MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 723.7K +24.4K (+3.5%) | 251.98M -6.5M (-2.5%) | 0.19% +0.006 pp | 0.17% -0.015 pp | USD299.89 +17.2% | 58 qtrs — |
| 61 | NATIONAL PENSION SERVICE | 706.4K +22.5K (+3.3%) | 248.27M -4.5M (-1.8%) | 0.18% +0.006 pp | 0.18% -0.013 pp | USD219.37 +60.2% | 46 qtrs — |
| 62 | CANADA PENSION PLAN INVESTMENT BOARD | 697.7K +131.9K (+23.3%) | 245.23M +36.0M (+17.2%) | 0.18% +0.035 pp | 0.16% +0.017 pp | USD358.34 -1.9% | 52 qtrs — |
| 63 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 674.4K -173.8K (-20.5%) | 237.02M -76.5M (-24.4%) | 0.18% -0.046 pp | 0.14% -0.052 pp | USD270.74 +29.8% | 58 qtrs — |
| 64 | QUBE RESEARCH & TECHNOLOGIES LTD | 650.6K +213.4K (+48.8%) | 228.65M +67.0M (+41.5%) | 0.17% +0.056 pp | 0.23% +0.065 pp | USD362.79 -3.1% | 11 qtrs — |
| 65 | ACADIAN ASSET MANAGEMENT LLC | 636.8K +399.2K (+168.0%) | 223.78M +136.0M (+154.8%) | 0.17% +0.105 pp | 0.37% +0.214 pp | USD355.52 -1.1% | 43 qtrs — |
| 66 | STIFEL FINANCIAL CORP | 633.4K -46.2K (-6.8%) | 222.63M -28.6M (-11.4%) | 0.17% -0.012 pp | 0.20% -0.029 pp | USD247.52 +42.0% | 48 qtrs — |
| 67 | RHUMBLINE ADVISERS | 627.9K -8.1K (-1.3%) | 220.69M -14.4M (-6.1%) | 0.16% -0.002 pp | 0.18% -0.010 pp | USD120.63 +191.4% | 55 qtrs — |
| 68 | TD ASSET MANAGEMENT INC | 615.1K -380.0K (-38.2%) | 216.20M -151.7M (-41.2%) | 0.16% -0.099 pp | 0.17% -0.125 pp | USD211.93 +65.8% | 51 qtrs — |
| 69 | HSBC HOLDINGS PLC | 608.6K -8.7K (-1.4%) | 214.06M -14.0M (-6.1%) | 0.16% -0.002 pp | 0.11% -0.017 pp | USD286.58 +22.6% | 56 qtrs — |
| 70 | MARINER, LLC | 606.4K +1.3K (+0.2%) | 213.14M -10.5M (-4.7%) | 0.16% +0.000 pp | 0.25% -0.035 pp | USD255.90 +37.3% | 56 qtrs — |
| 71 | ENSIGN PEAK ADVISORS, INC | 600.9K -16.5K (-2.7%) | 211.20M -17.0M (-7.5%) | 0.16% -0.004 pp | 0.37% -0.001 pp | USD213.58 +64.6% | 25 qtrs — |
| 72 | ABN AMRO BANK N.V. | 595.1K -78.9K (-11.7%) | 208.66M -39.5M (-15.9%) | 0.16% -0.021 pp | 1.96% -0.477 pp | USD364.03 -3.5% | 5 qtrs — |
| 73 | SG AMERICAS SECURITIES, LLC | 566.5K +493.6K (+676.8%) | 199.12M +172.2M (+638.6%) | 0.15% +0.129 pp | 0.25% +0.163 pp | USD356.55 -1.4% | 51 qtrs — |
| 74 | PRINCIPAL FINANCIAL GROUP INC | 552.7K +176.4K (+46.9%) | 194.25M +55.1M (+39.6%) | 0.14% +0.046 pp | 0.10% +0.029 pp | USD204.08 +72.2% | 81 qtrs — |
| 75 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 545.3K -5.9K (-1.1%) | 191.67M -12.1M (-5.9%) | 0.14% -0.002 pp | 0.19% -0.017 pp | USD111.31 +215.8% | 52 qtrs — |
| 76 | FENIMORE ASSET MANAGEMENT INC | 525.4K -59.0 (0.0%) | 184.65M -9.6M (-4.9%) | 0.14% +0.000 pp | 3.85% -0.049 pp | USD64.95 +441.1% | 68 qtrs — |
| 77 | CITADEL ADVISORS LLC | 521.5K +153.7K (+41.8%) | 183.29M +47.3M (+34.8%) | 0.14% +0.040 pp | 0.03% +0.007 pp | USD364.31 -3.5% | 2 qtrs — |
| 78 | PRIMECAP MANAGEMENT CO/CA/ | 516.8K +8.3K (+1.6%) | 181.64M -6.3M (-3.4%) | 0.14% +0.002 pp | 0.14% -0.007 pp | USD177.34 +98.2% | 56 qtrs — |
| 79 | SEI INVESTMENTS CO | 514.8K +87.2K (+20.4%) | 180.93M +22.8M (+14.4%) | 0.13% +0.023 pp | 0.18% +0.009 pp | USD337.25 +4.2% | 45 qtrs — |
| 80 | WELCH & FORBES LLC | 512.5K -1.1K (-0.2%) | 180.12M -9.7M (-5.1%) | 0.13% 0.000 pp | 2.18% -0.105 pp | USD53.50 +557.0% | 88 qtrs — |
| 81 | CREDIT AGRICOLE S A | 501.7K -23.2K (-4.4%) | 176.32M -17.7M (-9.1%) | 0.13% -0.006 pp | 0.40% -0.114 pp | USD369.67 -4.9% | 2 qtrs — |
| 82 | BANK OF MONTREAL /CAN/ | 500.8K +22.4K (+4.7%) | 176.02M -829.2K (-0.5%) | 0.13% +0.006 pp | 0.06% -0.007 pp | USD253.78 +38.5% | 51 qtrs — |
| 83 | D. E. SHAW & CO., INC. | 488.7K +372.0K (+318.9%) | 171.75M +128.6M (+298.3%) | 0.13% +0.097 pp | 0.09% +0.070 pp | USD349.48 +0.6% | 10 qtrs — |
| 84 | ALECTA TJANSTEPENSION OMSESIDIGT | 487.5K +29.2K (+6.4%) | 171.32M +1.9M (+1.1%) | 0.13% +0.008 pp | 0.75% -0.002 pp | USD376.49 -6.6% | 5 qtrs — |
| 85 | ENVESTNET ASSET MANAGEMENT INC | 482.6K -109.8K (-18.5%) | 169.61M -49.4M (-22.5%) | 0.13% -0.029 pp | 0.05% -0.013 pp | USD230.17 +52.7% | 51 qtrs — |
| 86 | KING LUTHER CAPITAL MANAGEMENT CORP | 481.3K +19.6K (+4.2%) | 169.15M -1.5M (-0.9%) | 0.13% +0.005 pp | 0.69% -0.015 pp | USD239.88 +46.5% | 23 qtrs — |
| 87 | WORLDQUANT MILLENNIUM ADVISORS LLC | 478.3K +428.0K (+852.2%) | 168.09M +149.5M (+805.3%) | 0.13% +0.112 pp | 0.65% +0.572 pp | USD353.38 -0.5% | 2 qtrs — |
| 88 | PICTET ASSET MANAGEMENT HOLDING SA | 466.3K +305.6K (+190.3%) | 163.88M +104.5M (+176.0%) | 0.12% +0.080 pp | 0.16% +0.102 pp | USD328.20 +7.1% | 10 qtrs — |
| 89 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 455.0K +432.5K (+1,925.0%) | 159.91M +151.6M (+1,825.3%) | 0.12% +0.113 pp | 0.09% +0.088 pp | USD352.37 -0.3% | 21 qtrs — |
| 90 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 448.4K +19.1K (+4.5%) | 158.01M -657.9K (-0.4%) | 0.12% +0.005 pp | 0.26% -0.007 pp | USD360.46 -2.5% | 5 qtrs — |
| 91 | HIGHTOWER ADVISORS, LLC | 444.5K +441.0 (+0.1%) | 156.24M -7.9M (-4.8%) | 0.12% +0.000 pp | 0.17% -0.016 pp | USD232.56 +51.1% | 59 qtrs — |
| 92 | LORD, ABBETT & CO. LLC | 436.5K -343.0 (-0.1%) | 153.43M -8.1M (-5.0%) | 0.11% 0.000 pp | 0.47% -0.010 pp | USD382.53 -8.1% | 10 qtrs — |
| 93 | STONEHAGE FLEMING FINANCIAL SERVICES HOLDINGS LTD | 434.7K -14.8K (-3.3%) | 152.77M -13.4M (-8.0%) | 0.11% -0.004 pp | 4.70% -0.013 pp | USD337.11 +4.3% | 11 qtrs — |
| 94 | CITIGROUP INC | 430.2K -61.7K (-12.5%) | 151.22M -30.6M (-16.8%) | 0.11% -0.016 pp | 0.07% -0.014 pp | USD310.13 +13.3% | 108 qtrs — |
| 95 | SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 419.8K +71.3K (+20.5%) | 147.55M +18.7M (+14.5%) | 0.11% +0.019 pp | 0.59% +0.075 pp | USD338.57 +3.8% | 41 qtrs — |
| 96 | LPL FINANCIAL LLC | 411.2K +9.6K (+2.4%) | 144.54M -3.9M (-2.6%) | 0.11% +0.003 pp | 0.04% -0.004 pp | USD282.07 +24.6% | 51 qtrs — |
| 97 | RENAISSANCE TECHNOLOGIES LLC | 406.2K +303.0K (+293.6%) | 142.75M +104.6M (+274.2%) | 0.11% +0.079 pp | 0.22% +0.171 pp | USD356.09 -1.3% | 2 qtrs — |
| 98 | FIL LTD | 404.1K +9.5K (+2.4%) | 142.01M -3.9M (-2.6%) | 0.11% +0.003 pp | 0.11% -0.008 pp | USD245.40 +43.2% | 40 qtrs — |
| 99 | CCLA INVESTMENT MANAGEMENT | 401.9K +17.8K (+4.6%) | 141.25M -729.0K (-0.5%) | 0.11% +0.005 pp | 2.27% -0.005 pp | USD248.83 +41.2% | 14 qtrs — |
| 100 | NEW YORK STATE COMMON RETIREMENT FUND | 397.2K -28.1K (-6.6%) | 139.62M -17.6M (-11.2%) | 0.10% -0.007 pp | 0.19% -0.017 pp | USD72.92 +382.0% | 103 qtrs — |
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-21 | Wells Preston Wendell | Officer | F-InKind | D | Common Stock | 204 | 335.67 | 68.5K | 6,498 | D | ↗ |
| 2026-03-21 | Stiles Spencer S | Officer | M-Exempt | A | Common Stock | 430 | 0.00 | — | 84,324 | D | ↗ |
| 2026-03-21 | Pierce James Andrew | Officer | M-Exempt | D | Dividend Equivalents | 430 | 0.00 | — | 0 | D | ↗ |
| 2026-03-21 | Menon Viju | Officer | M-Exempt | D | Dividend Equivalents | 269 | 0.00 | — | 0 | D | ↗ |
| 2026-03-21 | Lobo Kevin | Director / Officer | M-Exempt | D | Dividend Equivalents | 1,452 | 0.00 | — | 0 | D | ↗ |
| 2026-03-21 | Fletcher Robert S | Officer | M-Exempt | D | Dividend Equivalents | 225 | 0.00 | — | 0 | D | ↗ |
| 2026-03-21 | Fink M Kathryn | Officer | M-Exempt | D | Dividend Equivalents | 150 | 0.00 | — | 0 | D | ↗ |
| 2026-03-21 | Crotty Dylan Bram | Officer | F-InKind | D | Common Stock | 368 | 335.67 | 123.5K | 5,474 | D | ↗ |
| 2026-03-21 | Berry William E Jr | Officer | F-InKind | D | Common Stock | 176 | 335.67 | 59.1K | 3,426 | D | ↗ |
| 2026-03-09 | Pierce James Andrew | Officer | A-Award | A | Common Stock | 14,912 | 0.00 | — | 88,246 | D | ↗ |
| 2026-03-09 | Menon Viju | Officer | A-Award | A | Common Stock | 9,320 | 0.00 | — | 21,831 | D | ↗ |
| 2026-03-09 | Lobo Kevin | Director / Officer | A-Award | A | Common Stock | 50,332 | 0.00 | — | 247,271 | D | ↗ |
| 2026-02-23 | STRYKER RONDA E | Director | G-Gift | D | Common Stock | 55,600 | 0.00 | — | 2,231,173 | I | ↗ |
| 2026-02-17 | STRYKER RONDA E | Director | J-Other | D | Common Stock | 42,000 | 0.00 | — | 12,857,163 | I | ↗ |
| 2026-02-13 | STRYKER RONDA E | Director | G-Gift | D | Common Stock | 377,900 | 0.00 | — | 2,509,073 | I | ↗ |
| 2026-02-06 | Lobo Kevin | Director / Officer | M-Exempt | D | Employee Stock Option granted 02/10/2016 (right to buy) | 206,955 | 96.64 | 20.00M | 0 | D | ↗ |
| 2026-02-05 | STRYKER RONDA E | Director | S-Sale | D | Common Stock | 6,342 | 366.99 | 2.33M | 2,207,331 | I | ↗ |
| 2026-02-04 | Wells Preston Wendell | Officer | A-Award | A | Employee Stock Option granted 02/04/2026 (right to buy) | 11,974 | 360.82 | 4.32M | 11,974 | D | ↗ |
| 2026-02-04 | Stiles Spencer S | Officer | A-Award | A | Employee Stock Option granted 02/04/2026 (right to buy) | 19,956 | 360.82 | 7.20M | 19,956 | D | ↗ |
| 2026-02-04 | STRYKER RONDA E | Director | S-Sale | D | Common Stock | 2,160 | 368.56 | 796.1K | 2,457,331 | I | ↗ |
| 2026-02-04 | Pierce James Andrew | Officer | A-Award | A | Common Stock | 2,771 | 0.00 | — | 73,334 | D | ↗ |
| 2026-02-04 | Montagnino Kimberly Ann | Officer | A-Award | A | Employee Stock Option granted 02/04/2026 (right to buy) | 1,830 | 360.82 | 660.3K | 1,830 | D | ↗ |
| 2026-02-04 | Menon Viju | Officer | A-Award | A | Employee Stock Option granted 02/04/2026 (right to buy) | 10,310 | 360.82 | 3.72M | 10,310 | D | ↗ |
| 2026-02-04 | Lobo Kevin | Director / Officer | A-Award | A | Employee Stock Option granted 02/04/2026 (right to buy) | 58,206 | 360.82 | 21.00M | 58,206 | D | ↗ |
| 2026-02-04 | King Debra | Officer | A-Award | A | Employee Stock Option granted 02/04/2026 (right to buy) | 3,992 | 360.82 | 1.44M | 3,992 | D | ↗ |
| 2026-02-04 | Fletcher Robert S | Officer | A-Award | A | Employee Stock Option granted 02/04/2026 (right to buy) | 8,980 | 360.82 | 3.24M | 8,980 | D | ↗ |
| 2026-02-04 | Fink M Kathryn | Officer | A-Award | A | Employee Stock Option granted 02/04/2026 (right to buy) | 5,654 | 360.82 | 2.04M | 5,654 | D | ↗ |
| 2026-02-04 | Crotty Dylan Bram | Officer | A-Award | A | Employee Stock Option granted 02/04/2026 (right to buy) | 9,978 | 360.82 | 3.60M | 9,978 | D | ↗ |
| 2026-02-04 | Berry William E Jr | Officer | A-Award | A | Employee Stock Option granted 02/04/2026 (right to buy) | 2,391 | 360.82 | 862.7K | 2,391 | D | ↗ |
| 2026-02-03 | Stiles Spencer S | Officer | F-InKind | D | Common Stock | 7,692 | 368.14 | 2.83M | 68,982 | D | ↗ |
| 2026-02-02 | Pierce James Andrew | Officer | M-Exempt | A | Common Stock | 13,840 | 96.64 | 1.34M | 79,470 | D | ↗ |
| 2026-01-15 | Silvernail Andrew K | Director | F-InKind | D | Common Stock | 1,229 | 359.39 | 441.7K | 17,703 | D | ↗ |
| 2026-01-14 | STRYKER RONDA E | Director | M-Exempt | A | Common Stock | 4,570 | 96.64 | 441.6K | 5,783 | D | ↗ |
| 2026-01-01 | Crotty Dylan Bram | Officer | — | — | Employee Stock Option granted 02/07/2018 (right to buy) | 5,515 | 154.14 | 850.1K | 0 | D | ↗ |
| 2025-12-16 | Fink M Kathryn | Officer | F-InKind | D | Common Stock | 37 | 355.31 | 13.1K | 13,331 | D | ↗ |
| 2025-12-16 | Berry William E Jr | Officer | F-InKind | D | Common Stock | 28 | 355.31 | 9.9K | 2,805 | D | ↗ |
| 2025-11-21 | Pierce James Andrew | Officer | G-Gift | A | Common Stock | 106 | 0.00 | — | 713 | I | ↗ |
| 2025-11-20 | Wells Preston Wendell | Officer | S-Sale | D | Common Stock | 165 | 365.88 | 60.4K | 6,694 | D | ↗ |
| 2025-11-14 | Berry William E Jr | Officer | M-Exempt | A | Common Stock | 4,925 | 154.14 | 759.1K | 7,758 | D | ↗ |
| 2025-11-06 | STRYKER RONDA E | Director | S-Sale | D | Common Stock | 3,819 | 351.30 | 1.34M | 2,974,066 | I | ↗ |
| 2025-11-05 | STRYKER RONDA E | Director | S-Sale | D | Common Stock | 180 | 359.79 | 64.8K | 2,978,281 | I | ↗ |
| 2025-11-01 | Wells Preston Wendell | Officer | F-InKind | D | Common Stock | 404 | 356.24 | 143.9K | 6,859 | D | ↗ |
| 2025-08-25 | Menon Viju | Officer | S-Sale | D | Common Stock | 500 | 390.61 | 195.3K | 12,511 | D | ↗ |
| 2025-08-20 | Fletcher Robert S | Officer | S-Sale | D | Common Stock | 1,785 | 393.07 | 701.6K | 10,457 | D | ↗ |
| 2025-08-06 | STRYKER RONDA E | Director | S-Sale | D | Common Stock | 10,428 | 378.54 | 3.95M | 3,230,748 | I | ↗ |
| 2025-08-05 | King Debra | Officer | A-Award | A | Common Stock | 6,553 | 0.00 | — | 6,553 | D | ↗ |
| 2025-08-05 | Fink M Kathryn | Officer | A-Award | A | Common Stock | 917 | 0.00 | — | 13,367 | D | ↗ |
| 2025-08-01 | Montagnino Kimberly Ann | Officer | F-InKind | D | Common Stock | 155 | 392.73 | 60.9K | 1,195 | D | ↗ |
| 2025-08-01 | Fletcher Robert S | Officer | F-InKind | D | Common Stock | 441 | 392.73 | 173.2K | 12,242 | D | ↗ |
| 2025-05-27 | King Debra | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-05-12 | Berry William E Jr | Officer | S-Sale | D | Common Stock | 1,241 | 388.56 | 482.2K | 2,833 | D | ↗ |
| 2025-05-08 | Suri Rajeev | Director | A-Award | A | Common Stock | 560 | 0.00 | — | 6,428 | D | ↗ |
| 2025-05-08 | Skeete Tatum Lisa M | Director | A-Award | A | Common Stock | 560 | 0.00 | — | 4,443 | D | ↗ |
| 2025-05-08 | Silvernail Andrew K | Director | A-Award | A | Common Stock | 560 | 0.00 | — | 14,362 | D | ↗ |
| 2025-05-08 | STRYKER RONDA E | Director / 10% Owner | A-Award | A | Common Stock | 560 | 0.00 | — | 1,213 | D | ↗ |
| 2025-05-08 | Ruggeri Rachel | Director | A-Award | A | Common Stock | 560 | 0.00 | — | 1,239 | D | ↗ |
| 2025-05-08 | McCoy Sherilyn S | Director | A-Award | A | Common Stock | 560 | 0.00 | — | 6,428 | D | ↗ |
| 2025-05-08 | Maceda Emmanuel Perez | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-05-08 | Caforio Giovanni | Director | A-Award | A | Common Stock | 560 | 0.00 | — | 3,768 | D | ↗ |
| 2025-05-08 | BRAINERD MARY K | Director | A-Award | A | Common Stock | 560 | 0.00 | — | 7,028 | D | ↗ |
| 2025-05-06 | STRYKER RONDA E | Director / 10% Owner | S-Sale | D | Common Stock | 18,362 | 374.76 | 6.88M | 3,596,664 | I | ↗ |
| 2025-04-01 | Wells Preston Wendell | Officer | — | — | Employee Stock Option granted 02/07/2018 (right to buy) | 1,555 | 154.14 | 239.7K | 0 | D | ↗ |
| 2025-04-01 | Montagnino Kimberly Ann | Officer | — | — | Employee Stock Option granted 02/05/2025 (right to buy) | 1,376 | 392.39 | 539.9K | 0 | D | ↗ |
| 2025-03-21 | Stiles Spencer S | Officer | M-Exempt | D | Dividend Equivalents | 314 | 0.00 | — | 0 | D | ↗ |
| 2025-03-21 | Pierce James Andrew | Officer | M-Exempt | D | Dividend Equivalents | 314 | 0.00 | — | 0 | D | ↗ |
| 2025-03-21 | Menon Viju | Officer | M-Exempt | D | Dividend Equivalents | 187 | 0.00 | — | 0 | D | ↗ |
| 2025-03-21 | Lobo Kevin | Director / Officer | M-Exempt | D | Dividend Equivalents | 1,085 | 0.00 | — | 0 | D | ↗ |
| 2025-03-21 | Fletcher Robert S | Officer | F-InKind | D | Common Stock | 2,578 | 374.22 | 964.7K | 12,683 | D | ↗ |
| 2025-03-21 | Fink M Kathryn | Officer | M-Exempt | A | Common Stock | 102 | 0.00 | — | 14,157 | D | ↗ |
| 2025-03-21 | Boehnlein Glenn S | Officer | M-Exempt | A | Common Stock | 314 | 0.00 | — | 18,358 | D | ↗ |
| 2025-03-21 | Berry William E Jr | Officer | F-InKind | D | Common Stock | 192 | 374.22 | 71.9K | 5,581 | D | ↗ |
| 2025-03-21 | Becker Yin C | Officer | M-Exempt | A | Common Stock | 42 | 0.00 | — | 34,586 | D | ↗ |
| 2025-03-10 | Stiles Spencer S | Officer | A-Award | A | Common Stock | 12,916 | 0.00 | — | 68,289 | D | ↗ |
| 2025-03-10 | Pierce James Andrew | Officer | A-Award | A | Common Stock | 12,916 | 0.00 | — | 72,247 | D | ↗ |
| 2025-03-10 | Menon Viju | Officer | A-Award | A | Common Stock | 7,678 | 0.00 | — | 16,747 | D | ↗ |
| 2025-03-10 | Lobo Kevin | Director / Officer | A-Award | A | Common Stock | 44,507 | 0.00 | — | 144,540 | D | ↗ |
| 2025-03-10 | Fletcher Robert S | Officer | A-Award | A | Common Stock | 5,935 | 0.00 | — | 15,117 | D | ↗ |
| 2025-03-10 | Fink M Kathryn | Officer | A-Award | A | Common Stock | 4,189 | 0.00 | — | 14,055 | D | ↗ |
| 2025-03-10 | Boehnlein Glenn S | Officer | A-Award | A | Common Stock | 12,916 | 0.00 | — | 18,044 | D | ↗ |
| 2025-03-10 | Becker Yin C | Officer | A-Award | A | Common Stock | 1,746 | 0.00 | — | 34,544 | D | ↗ |
| 2025-02-27 | Becker Yin C | Officer | M-Exempt | A | Common Stock | 4,980 | 96.64 | 481.3K | 35,729 | D | ↗ |
| 2025-02-25 | STRYKER RONDA E | Director / 10% Owner | G-Gift | D | Common Stock | 141,026 | 0.00 | — | 3,615,026 | I | ↗ |
| 2025-02-24 | STRYKER RONDA E | Director / 10% Owner | G-Gift | D | Common Stock | 51,282 | 0.00 | — | 3,756,052 | I | ↗ |
| 2025-02-21 | STRYKER RONDA E | Director / 10% Owner | G-Gift | D | Common Stock | 192,308 | 0.00 | — | 3,666,308 | I | ↗ |
| 2025-02-19 | STRYKER RONDA E | Director / 10% Owner | G-Gift | D | Common Stock | 156,411 | 0.00 | — | 3,858,616 | I | ↗ |
| 2025-02-18 | Golston Allan C. | Director | M-Exempt | A | Common Stock | 3,605 | 122.51 | 441.6K | 18,500 | D | ↗ |
| 2025-02-14 | STRYKER RONDA E | Director / 10% Owner | G-Gift | D | Common Stock | 15,385 | 0.00 | — | 3,999,642 | I | ↗ |
| 2025-02-13 | STRYKER RONDA E | Director / 10% Owner | G-Gift | D | Common Stock | 307,691 | 0.00 | — | 3,299,776 | I | ↗ |
| 2025-02-11 | STRYKER RONDA E | Director / 10% Owner | G-Gift | D | Common Stock | 307,691 | 0.00 | — | 3,299,776 | I | ↗ |
| 2025-02-05 | Stiles Spencer S | Officer | A-Award | A | Employee Stock Option granted 02/05/2025 (right to buy) | 13,458 | 392.39 | 5.28M | 13,458 | D | ↗ |
| 2025-02-05 | Pierce James Andrew | Officer | A-Award | A | Employee Stock Option granted 02/05/2025 (right to buy) | 13,458 | 392.39 | 5.28M | 13,458 | D | ↗ |
| 2025-02-05 | Menon Viju | Officer | A-Award | A | Employee Stock Option granted 02/05/2025 (right to buy) | 8,258 | 392.39 | 3.24M | 8,258 | D | ↗ |
| 2025-02-05 | Lobo Kevin | Director / Officer | A-Award | A | Employee Stock Option granted 02/05/2025 (right to buy) | 48,936 | 392.39 | 19.20M | 48,936 | D | ↗ |
| 2025-02-05 | Fletcher Robert S | Officer | A-Award | A | Employee Stock Option granted 02/05/2025 (right to buy) | 7,646 | 392.39 | 3.00M | 7,646 | D | ↗ |
| 2025-02-05 | Fink M Kathryn | Officer | A-Award | A | Employee Stock Option granted 02/05/2025 (right to buy) | 4,894 | 392.39 | 1.92M | 4,894 | D | ↗ |
| 2025-02-05 | Berry William E Jr | Officer | A-Award | A | Employee Stock Option granted 02/05/2025 (right to buy) | 2,198 | 392.39 | 862.5K | 2,198 | D | ↗ |
| 2025-02-03 | Silvernail Andrew K | Director | M-Exempt | A | Common Stock | 3,795 | 93.06 | 353.2K | 14,705 | D | ↗ |
| 2025-01-31 | STRYKER RONDA E | Director / 10% Owner | S-Sale | D | Common Stock | 96,728 | 390.89 | 37.81M | 3,746,739 | I | ↗ |
| 2025-01-30 | STRYKER RONDA E | Director / 10% Owner | M-Exempt | A | Common Stock | 3,795 | 93.06 | 353.2K | 7,735 | D | ↗ |
| 2025-01-29 | Stiles Spencer S | Officer | F-InKind | D | Common Stock | 5,448 | 395.15 | 2.15M | 55,373 | D | ↗ |
| 2025-01-29 | Pierce James Andrew | Officer | M-Exempt | D | Employee Stock Option granted 02/11/2015 (right to buy) | 9,455 | 93.06 | 879.9K | 0 | D | ↗ |
| 2024-12-31 | Boehnlein Glenn S | Officer | M-Exempt | D | Employee Stock Option granted 2/8/2017 (right to buy) | 300 | 122.51 | 36.8K | 9,015 | D | ↗ |
| 2024-12-27 | Boehnlein Glenn S | Officer | M-Exempt | D | Employee Stock Option granted 2/8/2017 (right to buy) | 2,000 | 122.51 | 245.0K | 9,315 | D | ↗ |
| 2024-12-23 | Pierce James Andrew | Officer | G-Gift | D | Common Stock | 198 | 0.00 | — | 55,413 | D | ↗ |
| 2024-12-17 | Berry William E Jr | Officer | F-InKind | D | Common Stock | 30 | 372.70 | 11.2K | 5,040 | D | ↗ |
| 2024-11-18 | Boehnlein Glenn S | Officer | F-InKind | D | Common Stock | 2,979 | 390.08 | 1.16M | 4,373 | D | ↗ |
| 2024-11-15 | Stiles Spencer S | Officer | S-Sale | D | Common Stock | 514 | 391.16 | 201.1K | 50,611 | D | ↗ |
| 2024-11-14 | Stiles Spencer S | Officer | G-Gift | D | Common Stock | 129 | 0.00 | — | 51,125 | D | ↗ |
| 2024-11-07 | Lobo Kevin | Director / Officer | M-Exempt | A | Common Stock | 156,890 | 93.06 | 14.60M | 256,917 | D | ↗ |
| 2024-11-05 | STRYKER RONDA E | Director / 10% Owner | S-Sale | D | Common Stock | 49,028 | 367.60 | 18.02M | 3,186,635 | I | ↗ |
| 2024-11-05 | Becker Yin C | Officer | F-InKind | D | Common Stock | 3,189 | 366.90 | 1.17M | 30,749 | D | ↗ |
| 2024-10-01 | Stiles Spencer S | Officer | F-InKind | D | Common Stock | 552 | 361.26 | 199.4K | 51,254 | D | ↗ |
| 2024-10-01 | Pierce James Andrew | Officer | F-InKind | D | Common Stock | 641 | 361.26 | 231.6K | 55,611 | D | ↗ |
| 2024-09-17 | Fink M Kathryn | Officer | S-Sale | D | Common Stock | 635 | 364.57 | 231.5K | 14,686 | — | ↗ |
| 2024-09-16 | Fink M Kathryn | Officer | M-Exempt | A | Common Stock | 7,347 | 122.51 | 900.1K | 17,389 | — | ↗ |
| 2024-09-13 | Fink M Kathryn | Officer | S-Sale | D | Common Stock | 2,121 | 370.00 | 784.8K | 10,042 | — | ↗ |
| 2024-08-28 | Berry William E Jr | Officer | A-Award | A | Common Stock | 1,255 | 0.00 | — | 5,070 | — | ↗ |
| 2024-08-27 | Menon Viju | Officer | S-Sale | D | Common Stock | 600 | 355.00 | 213.0K | 9,069 | — | ↗ |
| 2024-08-06 | STRYKER RONDA E | Director / 10% Owner | S-Sale | D | Common Stock | 3,944 | 321.43 | 1.27M | 3,487,786 | — | ↗ |
| 2024-08-06 | Fletcher Robert S | Officer | A-Award | A | Common Stock | 633 | 0.00 | — | 9,182 | — | ↗ |
| 2024-08-02 | Boehnlein Glenn S | Officer | S-Sale | D | Common Stock | 20,000 | 333.00 | 6.66M | 2,852 | — | ↗ |
| 2024-08-01 | Fletcher Robert S | Officer | F-InKind | D | Common Stock | 347 | 327.45 | 113.6K | 8,549 | — | ↗ |
| 2024-07-02 | Boehnlein Glenn S | Officer | M-Exempt | A | Common Stock | 25,000 | 122.51 | 3.06M | 40,012 | — | ↗ |
| 2024-05-22 | Fletcher Robert S | Officer | S-Sale | D | Common Stock | 2,007 | 332.99 | 668.3K | 8,896 | — | ↗ |
| 2024-05-15 | Boehnlein Glenn S | Officer | S-Sale | D | Common Stock | 10,000 | 327.65 | 3.28M | 15,012 | — | ↗ |
| 2024-05-09 | Suri Rajeev | Director | A-Award | A | Common Stock | 653 | 0.00 | — | 5,868 | — | ↗ |
| 2024-05-09 | Skeete Tatum Lisa M | Director | A-Award | A | Common Stock | 653 | 0.00 | — | 3,883 | — | ↗ |
| 2024-05-09 | Silvernail Andrew K | Director | A-Award | A | Common Stock | 653 | 0.00 | — | 10,910 | — | ↗ |
| 2024-05-09 | STRYKER RONDA E | Director / 10% Owner | A-Award | A | Common Stock | 653 | 0.00 | — | 3,940 | — | ↗ |
| 2024-05-09 | Ruggeri Rachel | Director | A-Award | A | Common Stock | 653 | 0.00 | — | 679 | — | ↗ |
| 2024-05-09 | McCoy Sherilyn S | Director | A-Award | A | Common Stock | 653 | 0.00 | — | 5,868 | — | ↗ |
| 2024-05-09 | Golston Allan C. | Director | A-Award | A | Common Stock | 653 | 0.00 | — | 14,895 | — | ↗ |
| 2024-05-09 | Caforio Giovanni | Director | A-Award | A | Common Stock | 653 | 0.00 | — | 3,208 | — | ↗ |
| 2024-05-09 | BRAINERD MARY K | Director | A-Award | A | Common Stock | 653 | 0.00 | — | 6,468 | — | ↗ |
| 2024-05-01 | Menon Viju | Officer | F-InKind | D | Common Stock | 649 | 336.50 | 218.4K | 9,669 | — | ↗ |
| 2024-05-01 | Fink M Kathryn | Officer | F-InKind | D | Common Stock | 140 | 336.50 | 47.1K | 12,163 | — | ↗ |
| 2024-05-01 | Boehnlein Glenn S | Officer | F-InKind | D | Common Stock | 585 | 336.50 | 196.9K | 25,012 | — | ↗ |
| 2024-05-01 | Becker Yin C | Officer | F-InKind | D | Common Stock | 148 | 336.50 | 49.8K | 28,958 | — | ↗ |
| 2024-03-21 | Stiles Spencer S | Officer | M-Exempt | D | Dividend Equivalents | 203 | 0.00 | — | 0 | — | ↗ |
| 2024-03-21 | Pierce James Andrew | Officer | M-Exempt | D | Dividend Equivalents | 203 | 0.00 | — | 0 | — | ↗ |
| 2024-03-21 | Menon Viju | Officer | M-Exempt | D | Dividend Equivalents | 158 | 0.00 | — | 0 | — | ↗ |
| 2024-03-21 | Lobo Kevin | Director / Officer | M-Exempt | D | Dividend Equivalents | 905 | 0.00 | — | 0 | — | ↗ |
| 2024-03-21 | Fletcher Robert S | Officer | M-Exempt | D | Dividend Equivalents | 120 | 0.00 | — | 0 | — | ↗ |
| 2024-03-21 | Fink M Kathryn | Officer | M-Exempt | D | Dividend Equivalents | 83 | 0.00 | — | 0 | — | ↗ |
| 2024-03-21 | Boehnlein Glenn S | Officer | F-InKind | D | Common Stock | 5,555 | 353.19 | 1.96M | 25,597 | — | ↗ |
| 2024-03-21 | Berry William E Jr | Officer | F-InKind | D | Common Stock | 335 | 353.19 | 118.3K | 3,815 | — | ↗ |
| 2024-03-21 | Becker Yin C | Officer | M-Exempt | D | Dividend Equivalents | 36 | 0.00 | — | 0 | — | ↗ |
| 2024-03-11 | Stiles Spencer S | Officer | A-Award | A | Common Stock | 8,499 | 0.00 | — | 55,399 | — | ↗ |
| 2024-03-11 | Pierce James Andrew | Officer | A-Award | A | Common Stock | 8,499 | 0.00 | — | 60,461 | — | ↗ |
| 2024-03-11 | Menon Viju | Officer | A-Award | A | Common Stock | 6,610 | 0.00 | — | 13,604 | — | ↗ |
| 2024-03-11 | Lobo Kevin | Director / Officer | A-Award | A | Common Stock | 37,773 | 0.00 | — | 118,814 | — | ↗ |
| 2024-03-11 | Fletcher Robert S | Officer | A-Award | A | Common Stock | 5,035 | 0.00 | — | 13,023 | — | ↗ |
| 2024-03-11 | Fink M Kathryn | Officer | A-Award | A | Common Stock | 3,463 | 0.00 | — | 13,627 | — | ↗ |
| 2024-03-11 | Boehnlein Glenn S | Officer | A-Award | A | Common Stock | 10,702 | 0.00 | — | 30,896 | — | ↗ |
| 2024-03-11 | Becker Yin C | Officer | A-Award | A | Common Stock | 1,509 | 0.00 | — | 29,862 | — | ↗ |
| 2024-03-08 | Berry William E Jr | Officer | F-InKind | D | Common Stock | 1,005 | 357.62 | 359.4K | 2,643 | D | ↗ |
| 2024-03-07 | Berry William E Jr | Officer | M-Exempt | A | Common Stock | 7,960 | 122.51 | 975.2K | 21,335 | — | ↗ |
| 2024-02-09 | Boehnlein Glenn S | Officer | S-Sale | D | Common Stock | 9,600 | 342.81 | 3.29M | 20,194 | — | ↗ |
| 2024-02-07 | Stiles Spencer S | Officer | A-Award | A | Employee Stock Option granted 02/07/2024 (right to buy) | 19,780 | 339.77 | 6.72M | 19,780 | — | ↗ |
| 2024-02-07 | Pierce James Andrew | Officer | A-Award | A | Employee Stock Option granted 02/07/2024 (right to buy) | 19,780 | 339.77 | 6.72M | 19,780 | — | ↗ |
| 2024-02-07 | Menon Viju | Officer | A-Award | A | Employee Stock Option granted 02/07/2024 (right to buy) | 12,245 | 339.77 | 4.16M | 12,245 | — | ↗ |
| 2024-02-07 | Lobo Kevin | Director / Officer | A-Award | A | Employee Stock Option granted 02/07/2024 (right to buy) | 67,695 | 339.77 | 23.00M | 67,695 | — | ↗ |
| 2024-02-07 | Fletcher Robert S | Officer | A-Award | A | Employee Stock Option granted 02/07/2024 (right to buy) | 10,830 | 339.77 | 3.68M | 10,830 | — | ↗ |
| 2024-02-07 | Fink M Kathryn | Officer | A-Award | A | Employee Stock Option granted 02/07/2024 (right to buy) | 7,065 | 339.77 | 2.40M | 7,065 | — | ↗ |
| 2024-02-07 | Boehnlein Glenn S | Officer | A-Award | A | Employee Stock Option granted 02/07/2024 (right to buy) | 21,190 | 339.77 | 7.20M | 21,190 | — | ↗ |
| 2024-02-07 | Berry William E Jr | Officer | A-Award | A | Employee Stock Option granted 02/07/2024 (right to buy) | 3,210 | 339.77 | 1.09M | 3,210 | — | ↗ |
| 2024-02-07 | Becker Yin C | Officer | A-Award | A | Employee Stock Option granted 02/07/2024 (right to buy) | 3,060 | 339.77 | 1.04M | 3,060 | — | ↗ |
| 2024-02-06 | STRYKER RONDA E | Director / 10% Owner | S-Sale | D | Common Stock | 29,626 | 340.28 | 10.08M | 3,670,806 | — | ↗ |
| 2024-02-05 | STRYKER RONDA E | Director / 10% Owner | S-Sale | D | Common Stock | 2,006 | 346.00 | 694.1K | 3,755,128 | — | ↗ |
| 2024-02-05 | Becker Yin C | Officer | M-Exempt | A | Common Stock | 8,060 | 93.06 | 750.1K | 33,129 | — | ↗ |
| 2024-02-02 | STRYKER RONDA E | Director / 10% Owner | M-Exempt | D | Stock Option granted 2/12/2014 (right to buy) | 4,355 | 81.14 | 353.4K | 0 | — | ↗ |
| 2024-02-02 | Golston Allan C. | Director | S-Sale | D | Common Stock | 3,273 | 341.00 | 1.12M | 14,242 | — | ↗ |
| 2024-01-16 | Pierce James Andrew | Officer | M-Exempt | A | Common Stock | 10,230 | 81.14 | 830.1K | 57,999 | — | ↗ |
| 2024-01-11 | Boehnlein Glenn S | Officer | M-Exempt | D | Employee Stock Option granted 02/10/2016 (right to buy) | 49,150 | 96.64 | 4.75M | 0 | — | ↗ |
| 2023-12-20 | Pierce James Andrew | Officer | G-Gift | D | Common Stock | 262 | 0.00 | — | 47,769 | — | ↗ |
| 2023-12-19 | Berry William E Jr | Officer | F-InKind | D | Common Stock | 35 | 291.47 | 10.2K | 2,874 | — | ↗ |
| 2023-12-05 | Silvernail Andrew K | Director | M-Exempt | A | Common Stock | 4,355 | 81.14 | 353.4K | 11,472 | — | ↗ |
| 2023-12-04 | Datar Srikant M. | Director | M-Exempt | A | Common Stock | 1,795 | 93.06 | 167.0K | 5,611 | — | ↗ |
| 2023-12-01 | Datar Srikant M. | Director | S-Sale | D | Common Stock | 500 | 298.22 | 149.1K | 3,816 | — | ↗ |
| 2023-11-28 | Berry William E Jr | Officer | S-Sale | D | Common Stock | 573 | 292.28 | 167.5K | 2,909 | — | ↗ |
| 2023-11-28 | Becker Yin C | Officer | M-Exempt | D | Employee Stock Option granted 02/12/2014 (right to buy) | 8,875 | 81.14 | 720.1K | 0 | — | ↗ |
| 2023-11-27 | Boehnlein Glenn S | Officer | F-InKind | D | Common Stock | 7,594 | 293.64 | 2.23M | 8,976 | — | ↗ |
| 2023-11-17 | Stiles Spencer S | Officer | M-Exempt | A | Common Stock | 11,090 | 81.14 | 899.8K | 53,732 | — | ↗ |
| 2023-11-17 | Lobo Kevin | Director / Officer | S-Sale | D | Common Stock | 8,060 | 289.12 | 2.33M | 81,508 | — | ↗ |
| 2023-11-16 | Datar Srikant M. | Director | S-Sale | D | Common Stock | 500 | 291.92 | 146.0K | 4,316 | — | ↗ |
| 2023-11-15 | Datar Srikant M. | Director | S-Sale | D | Common Stock | 500 | 287.50 | 143.8K | 4,816 | — | ↗ |
| 2023-11-14 | Datar Srikant M. | Director | S-Sale | D | Common Stock | 750 | 287.57 | 215.7K | 5,316 | — | ↗ |
| 2023-11-01 | Stiles Spencer S | Officer | F-InKind | D | Common Stock | 714 | 270.22 | 192.9K | 42,731 | — | ↗ |
| 2023-10-01 | Stiles Spencer S | Officer | F-InKind | D | Common Stock | 549 | 273.27 | 150.0K | 43,445 | — | ↗ |
| 2023-10-01 | Pierce James Andrew | Officer | F-InKind | D | Common Stock | 627 | 273.27 | 171.3K | 48,031 | — | ↗ |
| 2023-09-06 | Menon Viju | Officer | S-Sale | D | Common Stock | 5,000 | 289.00 | 1.45M | 6,994 | — | ↗ |
| 2023-08-10 | Datar Srikant M. | Director | S-Sale | D | Common Stock | 750 | 286.23 | 214.7K | 6,066 | — | ↗ |
| 2023-08-08 | Datar Srikant M. | Director | M-Exempt | A | Common Stock | 2,000 | 93.06 | 186.1K | 7,467 | — | ↗ |
| 2023-08-01 | Fletcher Robert S | Officer | F-InKind | D | Common Stock | 338 | 283.41 | 95.8K | 7,988 | — | ↗ |
| 2023-06-09 | Lobo Kevin | Director / Officer | G-Gift | D | Common Stock | 8,904 | 0.00 | — | 80,959 | — | ↗ |
| 2023-06-05 | Lobo Kevin | Director / Officer | G-Gift | D | Common Stock | 8,904 | 0.00 | — | 80,959 | — | ↗ |
| 2023-06-01 | Datar Srikant M. | Director | S-Sale | D | Common Stock | 500 | 278.50 | 139.3K | 5,467 | — | ↗ |
| 2023-05-18 | Datar Srikant M. | Director | S-Sale | D | Common Stock | 1,000 | 286.00 | 286.0K | 5,967 | — | ↗ |
| 2023-05-10 | Suri Rajeev | Director | A-Award | A | Common Stock | 705 | 0.00 | — | 5,215 | — | ↗ |
| 2023-05-10 | Skeete Tatum Lisa M | Director | A-Award | A | Common Stock | 705 | 0.00 | — | 3,230 | — | ↗ |
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Kevin A. Lobo Chair, Chief Executive Officer and President | 1.49M | — | 9.76M | 6.92M | 2.25M | 974.9K | 21.40M | 77.96% | ↗ |
| 2 | 2025 | Spencer S. Stiles Group President, Orthopaedics | 792.5K | — | 2.69M | 1.90M | 760.0K | 188.1K | 6.33M | 72.50% | ↗ |
| 3 | 2025 | J. Andrew Pierce Group President, MedSurg and Neurotechnology | 792.5K | — | 2.69M | 1.90M | 754.1K | 188.1K | 6.32M | 72.57% | ↗ |
| 4 | 2025 | Preston W. Wells Vice President, Chief Financial Officer | 653.4K | — | 1.84M | 1.30M | 514.6K | 103.3K | 4.41M | 71.17% | ↗ |
| 5 | 2025 | Viju S. Menon Group President, Global Quality and Operations | 675.0K | — | 1.65M | 1.17M | 578.0K | 167.5K | 4.24M | 66.47% | ↗ |
| 6 | 2025 | Glenn S. Boehnlein Advisor to the Chief Executive Officer and Former Vice President, Chief Financial Officer | 800.0K | — | — | — | 800.0K | 293.0K | 1.89M | 0.00% | ↗ |
| 7 | 2024 | Kevin A. Lobo Chair, Chief Executive Officer and President | 1.44M | — | 8.70M | 8.00M | 2.94M | 897.9K | 21.98M | 76.00% | ↗ |
| 8 | 2024 | Glenn S. Boehnlein Vice President, Chief Financial Officer | 793.3K | — | 2.72M | 2.51M | 1.08M | 237.7K | 7.34M | 71.24% | ↗ |
| 9 | 2024 | Glenn S. Boehnlein Advisor to the Chief Executive Officer and Former Vice President, Chief Financial Officer | 793.3K | — | 2.72M | 2.51M | 1.08M | 237.7K | 7.34M | 71.24% | ↗ |
| 10 | 2024 | J. Andrew Pierce Group President, MedSurg and Neurotechnology | 750.0K | — | 2.54M | 2.34M | 917.3K | 211.7K | 6.76M | 72.20% | ↗ |
| 11 | 2024 | Spencer S. Stiles Group President, Orthopaedics | 750.0K | — | 2.54M | 2.34M | 917.3K | 211.7K | 6.76M | 72.20% | ↗ |
| 12 | 2024 | Viju S. Menon Group President, Global Quality and Operations | 645.8K | — | 1.57M | 1.45M | 745.9K | 176.2K | 4.59M | 65.84% | ↗ |
| 13 | 2023 | Kevin A. Lobo Chair, Chief Executive Officer and President | 1.39M | — | 6.65M | 8.41M | 3.78M | 532.7K | 20.77M | 72.53% | ↗ |
| 14 | 2023 | Glenn S. Boehnlein Vice President, Chief Financial Officer | 755.8K | — | 2.02M | 2.55M | 1.37M | 143.3K | 6.84M | 66.86% | ↗ |
| 15 | 2023 | Glenn S. Boehnlein Advisor to the Chief Executive Officer and Former Vice President, Chief Financial Officer | 755.8K | — | 2.02M | 2.55M | 1.37M | 143.3K | 6.84M | 66.86% | ↗ |
| 16 | 2023 | J. Andrew Pierce Group President, MedSurg and Neurotechnology | 720.8K | — | 1.97M | 2.49M | 1.17M | 131.5K | 6.49M | 68.77% | ↗ |
| 17 | 2023 | Spencer S. Stiles Group President, Orthopaedics and Spine | 720.8K | — | 1.97M | 2.49M | 1.17M | 129.0K | 6.49M | 68.80% | ↗ |
| 18 | 2023 | Spencer S. Stiles Group President, Orthopaedics | 720.8K | — | 1.97M | 2.49M | 1.17M | 129.0K | 6.49M | 68.80% | ↗ |
| 19 | 2023 | Viju S. Menon Group President, Global Quality and Operations | 616.7K | — | 1.23M | 1.56M | 956.3K | 107.8K | 4.47M | 62.40% | ↗ |
| 20 | 2022 | Kevin A. Lobo Chair, Chief Executive Officer and President | 1.34M | — | 6.53M | 8.73M | 1.51M | 458.5K | 18.56M | 82.18% | ↗ |
| 21 | 2022 | Glenn S. Boehnlein Vice President, Chief Financial Officer | 730.8K | — | 1.89M | 2.53M | 546.5K | 148.8K | 5.85M | 75.63% | ↗ |
| 22 | 2022 | J. Andrew Pierce Group President, MedSurg and Neurotechnology | 695.8K | — | 1.89M | 2.53M | 475.0K | 144.9K | 5.74M | 77.09% | ↗ |
| 23 | 2022 | Spencer S. Stiles Group President, Orthopaedics and Spine | 695.8K | — | 1.89M | 2.53M | 452.3K | 136.7K | 5.71M | 77.51% | ↗ |
| 24 | 2022 | Spencer S. Stiles Group President, Orthopaedics | 695.8K | — | 1.89M | 2.53M | 452.3K | 136.7K | 5.71M | 77.51% | ↗ |
| 25 | 2022 | Viju S. Menon Group President, Global Quality and Operations | 571.7K | — | 1.13M | 1.51M | 363.4K | 110.7K | 3.68M | 71.56% | ↗ |
| 26 | 2021 | Kevin A. Lobo Chair, Chief Executive Officer and President | 1.31M | — | 5.97M | 6.80M | 1.82M | 469.5K | 16.36M | 78.04% | ↗ |
| 27 | 2021 | Timothy J. Scannell Executive Advisor | 820.8K | — | 2.98M | 3.40M | 760.9K | 156.3K | 8.12M | 78.60% | ↗ |
| 28 | 2021 | Glenn S. Boehnlein Vice President, Chief Financial Officer | 705.0K | — | 2.63M | 1.93M | 622.1K | 130.8K | 6.02M | 75.76% | ↗ |
| 29 | 2021 | J. Andrew Pierce Group President, MedSurg and Neurotechnology | 666.7K | — | 2.33M | 1.53M | 621.8K | 117.2K | 5.26M | 73.29% | ↗ |
| 30 | 2021 | Spencer S. Stiles Group President, Orthopaedics and Spine | 666.7K | — | 2.33M | 1.53M | 546.8K | 117.2K | 5.19M | 74.35% | ↗ |
| 31 | 2021 | Viju S. Menon Group President, Global Quality and Operations | 551.7K | — | 1.98M | 1.19M | 435.1K | 98.2K | 4.26M | 74.53% | ↗ |
| 32 | 2020 | Kevin A. Lobo Chair and CEO | 1.11M | — | 5.43M | 4.91M | 1.43M | 430.3K | 13.32M | 77.67% | ↗ |
| 33 | 2020 | Kevin A. Lobo Chair, Chief Executive Officer and President | 1.11M | — | 5.43M | 4.91M | 1.43M | 430.3K | 13.32M | 77.67% | ↗ |
| 34 | 2020 | Timothy J. Scannell Executive Advisor | 735.8K | — | 2.62M | 2.36M | 600.0K | 202.0K | 6.52M | 76.41% | ↗ |
| 35 | 2020 | Timothy J. Scannell President and COO | 735.8K | — | 2.62M | 2.36M | 600.0K | 202.0K | 6.52M | 76.41% | ↗ |
| 36 | 2020 | Glenn S. Boehnlein Vice President, Chief Financial Officer | 634.2K | — | 1.61M | 1.45M | 484.5K | 162.5K | 4.35M | 70.52% | ↗ |
| 37 | 2020 | Glenn S. Boehnlein Vice President, CFO | 634.2K | — | 1.61M | 1.45M | 484.5K | 162.5K | 4.35M | 70.52% | ↗ |
| 38 | 2020 | Viju S. Menon Group President, Global Quality and Operations | 504.9K | — | 956.3K | 863.5K | 341.1K | 307.7K | 2.97M | 61.20% | ↗ |
| 39 | 2020 | Robert S. Fletcher Vice President, Chief Legal Officer | 504.9K | — | 704.6K | 636.2K | 300.9K | 90.0K | 2.24M | 59.95% | ↗ |
| 40 | 2019 | Kevin A. Lobo Chair and CEO | 1.23M | — | 5.29M | 5.31M | 2.63M | 510.4K | 14.97M | 70.80% | ↗ |
| 41 | 2019 | Kevin A. Lobo Chairman and CEO | 1.23M | — | 5.29M | 5.31M | 2.63M | 510.4K | 14.97M | 70.80% | ↗ |
| 42 | 2019 | Kevin A. Lobo Chair, Chief Executive Officer and President | 1.23M | — | 5.29M | 5.31M | 2.63M | 510.4K | 14.97M | 70.80% | ↗ |
| 43 | 2019 | Timothy J. Scannell President and COO | 770.8K | — | 2.52M | 2.53M | 1.10M | 193.2K | 7.11M | 70.98% | ↗ |
| 44 | 2019 | Timothy J. Scannell Executive Advisor | 770.8K | — | 2.52M | 2.53M | 1.10M | 193.2K | 7.11M | 70.98% | ↗ |
| 45 | 2019 | Glenn S. Boehnlein Vice President, Chief Financial Officer | 650.0K | — | 1.36M | 1.37M | 843.4K | 156.0K | 4.38M | 62.31% | ↗ |
| 46 | 2019 | Glenn S. Boehnlein Vice President, CFO | 650.0K | — | 1.36M | 1.37M | 843.4K | 156.0K | 4.38M | 62.31% | ↗ |
| 47 | 2019 | Robert S. Fletcher Vice President, Chief Legal Officer | 357.0K | 75.0K | 2.32M | — | 356.2K | 43.0K | 3.15M | 73.59% | ↗ |
| 48 | 2019 | Viju S. Menon Group President, Global Quality and Operations | 512.5K | — | 881.5K | 885.5K | 621.5K | 124.2K | 3.03M | 58.41% | ↗ |
| 49 | 2018 | Kevin A. Lobo Chair and CEO | 1.19M | — | 4.98M | 4.61M | 2.71M | 413.7K | 13.91M | 68.96% | ↗ |
| 50 | 2018 | Kevin A. Lobo Chairman and CEO | 1.19M | — | 4.98M | 4.61M | 2.71M | 413.7K | 13.91M | 68.96% | ↗ |
| 51 | 2018 | Timothy J. Scannell President and COO | 691.3K | — | 3.38M | 1.43M | 986.0K | 146.1K | 6.63M | 72.51% | ↗ |
| 52 | 2018 | Viju S. Menon Group President, GQO | 344.7K | 130.0K | 1.69M | 1.69M | 443.5K | 95.9K | 4.39M | 76.92% | ↗ |
| 53 | 2018 | Viju S. Menon Group President, Global Quality and Operations | 344.7K | 130.0K | 1.69M | 1.69M | 443.5K | 95.9K | 4.39M | 76.92% | ↗ |
| 54 | 2018 | David K. Floyd Group President and Advisor to the CEO | 636.7K | — | 1.40M | 1.29M | 692.6K | 174.0K | 4.19M | 64.12% | ↗ |
| 55 | 2018 | Glenn S. Boehnlein Vice President, CFO | 595.0K | — | 1.20M | 1.11M | 767.8K | 123.4K | 3.79M | 60.77% | ↗ |
| 56 | 2018 | Lonny J. Carpenter Group President and Advisor to the CEO | 540.8K | — | 1.20M | 1.11M | 688.1K | 116.0K | 3.65M | 63.12% | ↗ |
| 57 | 2018 | Michael D. Hutchinson Vice President, Chief Legal Officer | 520.8K | — | 598.1K | 553.0K | 592.8K | 73.5K | 2.34M | 49.23% | ↗ |
| 58 | 2017 | Kevin A. Lobo Chairman and CEO | 1.16M | — | 6.18M | 4.34M | 1.89M | 431.8K | 14.01M | 75.10% | ↗ |
| 59 | 2017 | Kevin A. Lobo Chairman, President and Chief Executive Officer | 1.16M | — | 6.18M | 4.34M | 1.89M | 431.8K | 14.01M | 75.10% | ↗ |
| 60 | 2017 | Timothy J. Scannell Group President, MedSurg and Neurotechnology | 631.7K | — | 1.91M | 1.33M | 636.9K | 154.2K | 4.66M | 69.46% | ↗ |
| 61 | 2017 | Timothy J. Scannell President and COO | 631.7K | — | 1.91M | 1.33M | 636.9K | 154.2K | 4.66M | 69.46% | ↗ |
| 62 | 2017 | David K. Floyd Group President, Orthopaedics | 613.3K | — | 1.70M | 1.23M | 606.4K | 133.5K | 4.29M | 68.44% | ↗ |
| 63 | 2017 | David K. Floyd Group President and Advisor to the CEO | 613.3K | — | 1.70M | 1.23M | 606.4K | 133.5K | 4.29M | 68.44% | ↗ |
| 64 | 2017 | Lonny J. Carpenter Group President, Global Quality and Business Operations | 516.7K | — | 1.45M | 1.05M | 510.9K | 109.0K | 3.63M | 68.72% | ↗ |
| 65 | 2017 | Lonny J. Carpenter Group President and Advisor to the CEO | 516.7K | — | 1.45M | 1.05M | 510.9K | 109.0K | 3.63M | 68.72% | ↗ |
| 66 | 2017 | Glenn S. Boehnlein Vice President, Chief Financial Officer | 577.6K | — | 999.1K | 914.2K | 527.1K | 123.2K | 3.14M | 60.91% | ↗ |
| 67 | 2017 | Glenn S. Boehnlein Vice President, CFO | 577.6K | — | 999.1K | 914.2K | 527.1K | 123.2K | 3.14M | 60.91% | ↗ |
| 68 | 2016 | Kevin A. Lobo Chairman, President and Chief Executive Officer | 1.13M | — | 5.39M | 3.67M | 2.28M | 336.3K | 12.80M | 70.76% | ↗ |
| 69 | 2016 | Kevin A. Lobo Chairman and CEO | 1.13M | — | 5.39M | 3.67M | 2.28M | 336.3K | 12.80M | 70.76% | ↗ |
| 70 | 2016 | Timothy J. Scannell Group President, MedSurg and Neurotechnology | 610.3K | — | 1.91M | 1.33M | 769.8K | 146.2K | 4.77M | 68.00% | ↗ |
| 71 | 2016 | Timothy J. Scannell President and COO | 610.3K | — | 1.91M | 1.33M | 769.8K | 146.2K | 4.77M | 68.00% | ↗ |
| 72 | 2016 | David K. Floyd Group President and Advisor to the CEO | 575.0K | — | 1.60M | 1.15M | 600.6K | 127.2K | 4.05M | 67.83% | ↗ |
| 73 | 2016 | David K. Floyd Group President, Orthopaedics | 575.0K | — | 1.60M | 1.15M | 600.6K | 127.2K | 4.05M | 67.83% | ↗ |
| 74 | 2016 | Lonny J. Carpenter Group President and Advisor to the CEO | 497.5K | — | 1.33M | 962.7K | 573.1K | 93.9K | 3.46M | 66.33% | ↗ |
| 75 | 2016 | Lonny J. Carpenter Group President, Global Quality and Business Operations | 497.5K | — | 1.33M | 962.7K | 573.1K | 93.9K | 3.46M | 66.33% | ↗ |
| 76 | 2016 | Glenn S. Boehnlein Vice President, CFO | 517.3K | — | 964.3K | 871.0K | 542.3K | 91.4K | 2.99M | 61.46% | ↗ |
| 77 | 2016 | Glenn S. Boehnlein Vice President, Chief Financial Officer | 517.3K | — | 964.3K | 871.0K | 542.3K | 91.4K | 2.99M | 61.46% | ↗ |
| 78 | 2016 | Glenn S. Boehnlein Vice President and Chief Financial Officer | 517.3K | — | 964.3K | 871.0K | 542.3K | 91.4K | 2.99M | 61.46% | ↗ |
| 79 | 2016 | William R. Jellison Advisor to the Chief Financial Officer and Former | 554.0K | 387.8K | — | — | — | 114.3K | 1.06M | 0.00% | ↗ |
| 80 | 2015 | Kevin A. Lobo Chairman, President and Chief Executive Officer | 1.09M | — | 3.65M | 3.54M | 1.93M | 265.5K | 10.47M | 68.61% | ↗ |
| 81 | 2015 | Timothy J. Scannell Group President, MedSurg and Neurotechnology | 584.3K | — | 1.68M | 1.28M | 718.7K | 125.4K | 4.40M | 67.51% | ↗ |
| 82 | 2015 | David K. Floyd Group President, Orthopaedics | 545.0K | — | 1.17M | 945.0K | 644.8K | 98.0K | 3.40M | 62.12% | ↗ |
| 83 | 2015 | Lonny J. Carpenter Group President, Global Quality and Business Operations | 481.7K | — | 1.26M | 872.3K | 441.9K | 85.4K | 3.14M | 67.88% | ↗ |
| 84 | 2015 | William R. Jellison Advisor to the Chief Financial Officer and Former | 551.5K | — | 624.3K | 605.8K | 485.5K | 99.2K | 2.37M | 51.99% | ↗ |
| 85 | 2015 | William R. Jellison Vice President, Chief Financial Officer | 551.5K | — | 624.3K | 605.8K | 485.5K | 99.2K | 2.37M | 51.99% | ↗ |
| 86 | 2014 | Kevin A. Lobo Chairman, President and Chief Executive Officer | 1.06M | — | 3.25M | 3.23M | 1.32M | 263.5K | 9.12M | 71.07% | ↗ |
| 87 | 2014 | Kevin A. Lobo Chairman, President and Chief Executive Officer | 1.06M | — | 3.25M | 3.23M | 1.32M | 263.5K | 9.12M | 71.07% | ↗ |
| 88 | 2014 | Timothy J. Scannell Group President, MedSurg and Neurotechnology | 568.5K | — | 1.05M | 1.04M | 555.2K | 106.5K | 3.32M | 62.99% | ↗ |
| 89 | 2014 | Timothy J. Scannell Group President, MedSurg and Spine | 568.5K | — | 1.05M | 1.04M | 555.2K | 106.5K | 3.32M | 62.99% | ↗ |
| 90 | 2014 | Ramesh Subrahmanian Group President, International | 526.7K | — | 800.0K | 795.5K | 288.2K | 515.1K | 2.93M | 54.54% | ↗ |
| 91 | 2014 | David K. Floyd Group President, Orthopaedics | 513.3K | — | 800.0K | 795.5K | 346.2K | 85.6K | 2.54M | 62.80% | ↗ |
| 92 | 2014 | David K. Floyd Group President, Orthopaedics | 513.3K | — | 800.0K | 795.5K | 346.2K | 85.6K | 2.54M | 62.80% | ↗ |
| 93 | 2014 | William R. Jellison Vice President, Chief | 536.7K | — | 624.9K | 621.4K | 350.2K | 86.3K | 2.22M | 56.15% | ↗ |
| 94 | 2014 | William R. Jellison Advisor to the Chief Financial Officer and Former | 536.7K | — | 624.9K | 621.4K | 350.2K | 86.3K | 2.22M | 56.15% | ↗ |
| 95 | 2014 | William R. Jellison Vice President, Chief Financial Officer | 536.7K | — | 624.9K | 621.4K | 350.2K | 86.3K | 2.22M | 56.15% | ↗ |
| 96 | 2013 | Kevin A. Lobo Chairman, President and Chief Executive Officer | 1.03M | — | 3.00M | 2.85M | 1.34M | 217.7K | 8.44M | 69.39% | ↗ |
| 97 | 2013 | Kevin A. Lobo President and Chief Executive Officer | 1.03M | — | 3.00M | 2.85M | 1.34M | 217.7K | 8.44M | 69.39% | ↗ |
| 98 | 2013 | Kevin A. Lobo Chairman, President and Chief Executive Officer | 1.03M | — | 3.00M | 2.85M | 1.34M | 217.7K | 8.44M | 69.39% | ↗ |
| 99 | 2013 | Ramesh Subrahmanian Group President, International | 512.5K | — | 749.9K | 713.6K | 345.2K | 874.9K | 3.20M | 45.79% | ↗ |
| 100 | 2013 | Timothy J. Scannell Group President, MedSurg and Neurotechnology | 553.3K | — | 1,000.0K | 951.4K | 399.9K | 99.9K | 3.00M | 64.95% | ↗ |
| 101 | 2013 | Timothy J. Scannell Group President, MedSurg and Spine | 553.3K | — | 1,000.0K | 951.4K | 399.9K | 99.9K | 3.00M | 64.95% | ↗ |
| 102 | 2013 | David K. Floyd Group President, Orthopaedics | 477.5K | — | 749.9K | 713.6K | 416.0K | 471.0K | 2.83M | 51.75% | ↗ |
| 103 | 2013 | David K. Floyd Group President, Orthopaedics | 477.5K | — | 749.9K | 713.6K | 416.0K | 471.0K | 2.83M | 51.75% | ↗ |
| 104 | 2013 | William R. Jellison Vice President, Chief Financial Officer | 363.9K | 67.5K | 985.7K | 974.1K | 248.2K | 174.0K | 2.81M | 69.66% | ↗ |
| 105 | 2013 | William R. Jellison Vice President, Chief | 363.9K | 67.5K | 985.7K | 974.1K | 248.2K | 174.0K | 2.81M | 69.66% | ↗ |
| 106 | 2013 | Dean H. Bergy Vice President, | 349.8K | 205.2K | 120.2K | 122.0K | 73.8K | 78.3K | 949.3K | 25.52% | ↗ |
| 107 | 2012 | Stephen P. MacMillan Formerly Chairman, President and Chief | 208.3K | — | 1.99M | 3.78M | — | 5.60M | 11.59M | 49.85% | ↗ |
| 108 | 2012 | Kevin A. Lobo President and Chief | 585.4K | 80.0K | 5.93M | 1.79M | 465.4K | 376.4K | 9.23M | 83.67% | ↗ |
| 109 | 2012 | Kevin A. Lobo Chairman, President and Chief Executive Officer | 585.4K | 80.0K | 5.93M | 1.79M | 465.4K | 376.4K | 9.23M | 83.67% | ↗ |
| 110 | 2012 | Kevin A. Lobo President and Chief Executive Officer | 585.4K | 80.0K | 5.93M | 1.79M | 465.4K | 376.4K | 9.23M | 83.67% | ↗ |
| 111 | 2012 | Curt R. Hartman Formerly Vice President and Chief Financial | 708.3K | — | 2.19M | 699.8K | 565.5K | 1.75M | 5.91M | 48.91% | ↗ |
| 112 | 2012 | Ramesh Subrahmanian | 500.0K | — | 1.11M | 374.2K | 246.1K | 551.5K | 2.78M | 53.36% | ↗ |
| 113 | 2012 | Ramesh Subrahmanian Group President, International | 500.0K | — | 1.11M | 374.2K | 246.1K | 551.5K | 2.78M | 53.36% | ↗ |
| 114 | 2012 | Timothy J. Scannell Group President, MedSurg and Spine | 507.2K | — | 1.26M | 482.7K | 354.7K | 87.4K | 2.69M | 64.67% | ↗ |
| 115 | 2012 | Lonny J. Carpenter Group President, | 407.4K | — | 1.11M | 374.2K | 226.2K | 68.1K | 2.19M | 67.90% | ↗ |
| 116 | 2012 | Dean H. Bergy Vice President and Chief Financial Officer | 320.7K | 97.0K | 120.0K | 97.0K | 59.6K | 38.1K | 732.5K | 29.64% | ↗ |
| 117 | 2012 | Dean H. Bergy Advisor to the Vice President and Chief Financial Officer | 320.7K | 97.0K | 120.0K | 97.0K | 59.6K | 38.1K | 732.5K | 29.64% | ↗ |
| 118 | 2011 | Stephen P. MacMillan Chairman, President and Chief Executive Officer | 1.25M | — | 3.60M | 3.11M | 1.17M | 418.4K | 9.54M | 70.29% | ↗ |
| 119 | 2011 | Stephen P. MacMillan Formerly Chairman, President and Chief | 1.25M | — | 3.60M | 3.11M | 1.17M | 418.4K | 9.54M | 70.29% | ↗ |
| 120 | 2011 | Andrew G. Fox-Smith Advisor to the Chief Executive Officer and Former Group President, International | 441.5K | — | 704.9K | 609.2K | 297.1K | 471.2K | 2.52M | 52.07% | ↗ |
| 121 | 2011 | Kevin A. Lobo President and Chief Executive Officer | 288.8K | — | 479.7K | 428.4K | 162.0K | 950.8K | 2.31M | 39.32% | ↗ |
| 122 | 2011 | Kevin A. Lobo President and Chief | 288.8K | — | 479.7K | 428.4K | 162.0K | 950.8K | 2.31M | 39.32% | ↗ |
| 123 | 2011 | Kevin A. Lobo President and Chief Executive Officer | 288.8K | — | 479.7K | 428.4K | 162.0K | 950.8K | 2.31M | 39.32% | ↗ |
| 124 | 2011 | Curt R. Hartman Vice President and Chief Financial Officer | 500.0K | — | 719.6K | 622.0K | 327.6K | 99.9K | 2.27M | 59.12% | ↗ |
| 125 | 2011 | Curt R. Hartman Formerly Vice President and Chief Financial | 500.0K | — | 719.6K | 622.0K | 327.6K | 99.9K | 2.27M | 59.12% | ↗ |
| 126 | 2011 | Timothy J. Scannell Group President, MedSurg and Spine | 460.0K | — | 687.6K | 594.3K | 270.1K | 98.4K | 2.11M | 60.74% | ↗ |
| 127 | 2011 | Lonny J. Carpenter Group President and Advisor to the CEO | 362.0K | — | 533.1K | 460.7K | 210.9K | 76.6K | 1.64M | 60.47% | ↗ |
| 128 | 2011 | Lonny J. Carpenter Group President, | 362.0K | — | 533.1K | 460.7K | 210.9K | 76.6K | 1.64M | 60.47% | ↗ |
| 129 | 2010 | Stephen P. MacMillan Chairman, President and Chief Executive Officer | 1.20M | — | — | 1.91M | 1.38M | 225.2K | 4.71M | 40.49% | ↗ |
| 130 | 2010 | Stephen P. MacMillan Formerly Chairman, President and Chief | 1.20M | — | — | 1.91M | 1.14M | 225.2K | 4.71M | 40.49% | ↗ |
| 131 | 2010 | Michael P. Mogul Group President, Orthopaedics | 490.0K | — | — | 1.19M | 470.1K | 650.5K | 2.80M | 42.42% | ↗ |
| 132 | 2010 | Andrew G. Fox-Smith Group President, International | 431.5K | — | — | 1.19M | 311.8K | 382.2K | 2.31M | 51.32% | ↗ |
| 133 | 2010 | Andrew G. Fox-Smith Advisor to the Chief Executive Officer and Former Group President, International | 431.5K | — | — | 1.19M | 311.8K | 382.2K | 2.31M | 51.32% | ↗ |
| 134 | 2010 | Curt R. Hartman Vice President and Chief Financial Officer | 430.0K | 34.5K | — | 1.09M | 295.5K | 60.9K | 1.91M | 57.05% | ↗ |
| 135 | 2010 | Curt R. Hartman Formerly Vice President and Chief Financial | 430.0K | 35.5K | — | 1.09M | 295.5K | 60.9K | 1.91M | 57.05% | ↗ |
| 136 | 2010 | Timothy J. Scannell Group President, MedSurg and Spine | 435.0K | — | — | 1.09M | 295.2K | 61.6K | 1.88M | 57.94% | ↗ |
| 137 | 2009 | Stephen P. MacMillan Chairman, President and Chief Executive Officer | 1.20M | — | — | 1.96M | 540.0K | 208.5K | 3.91M | 50.19% | ↗ |
| 138 | 2009 | Andrew G. Fox-Smith Advisor to the Chief Executive Officer and Former Group President, International | 412.3K | 9.7K | 607.5K | 1.21M | 147.4K | 379.3K | 2.77M | 65.71% | ↗ |
| 139 | 2009 | Andrew G. Fox-Smith Group President, International | 412.3K | 9.7K | 607.5K | 1.21M | 147.4K | 379.3K | 2.77M | 65.71% | ↗ |
| 140 | 2009 | Michael P. Mogul Group President, Orthopaedics | 446.7K | 31.6K | 607.5K | 1.21M | 277.6K | 113.0K | 2.69M | 67.66% | ↗ |
| 141 | 2009 | Michael P. Mogul Group President, Orthopaedics | 446.7K | 31.6K | 607.5K | 1.21M | 277.6K | 113.0K | 2.69M | 67.66% | ↗ |
| 142 | 2009 | Timothy J. Scannell Group President, MedSurg and Spine | 415.0K | — | 607.5K | 1.11M | 124.7K | 65.6K | 2.33M | 73.97% | ↗ |
| 143 | 2009 | Timothy J. Scannell Group President, MedSurg and Spine | 415.0K | — | 607.5K | 1.11M | 124.7K | 65.6K | 2.33M | 73.97% | ↗ |
| 144 | 2009 | Curt R. Hartman Vice President and Chief Financial Officer | 410.0K | 9.2K | 607.5K | 1.11M | 114.0K | 59.8K | 2.31M | 74.36% | ↗ |
| 145 | 2009 | Dean H. Bergy Advisor to the Vice President and Chief Financial Officer | 450.0K | — | — | — | — | 66.2K | 516.2K | 0.00% | ↗ |
| 146 | 2008 | Stephen P. MacMillan President and Chief Executive Officer | 1.20M | — | 280.6K | — | 617.3K | 300.8K | 5.90M | 4.75% | ↗ |
| 147 | 2008 | Stephen Si Johnson Vice President; Group President, MedSurg | 545.0K | — | — | — | 369.5K | 142.6K | 2.62M | 0.00% | ↗ |
| 148 | 2008 | James E. Kemler Vice President; Group President, BOD | 460.0K | — | — | — | 215.4K | 111.7K | 2.21M | 0.00% | ↗ |
| 149 | 2008 | Stephen P. MacMillan Chairman, President and Chief Executive Officer | 1.20M | — | — | — | 617.3K | 300.8K | 2.12M | 0.00% | ↗ |
| 150 | 2008 | Andrew G. Fox-Smith Group President, International | 400.4K | — | — | 1.09M | 125.5K | 361.1K | 1.98M | 55.22% | ↗ |
| 151 | 2008 | Dean H. Bergy Vice President and Chief Financial Officer | 450.0K | — | — | — | 149.3K | 96.3K | 1.75M | 0.00% | ↗ |
| 152 | 2008 | Dean H. Bergy Advisor to the Vice President and Chief Financial Officer | 450.0K | — | — | 1.05M | 149.3K | 96.3K | 1.75M | 60.15% | ↗ |
| 153 | 2008 | Curt R. Hartman Vice President, Finance | 360.7K | — | — | — | 132.0K | 63.2K | 1.48M | 0.00% | ↗ |
| 154 | 2008 | Curt R. Hartman Vice President and Chief Financial Officer | 360.7K | — | — | 875.2K | 132.0K | 63.2K | 1.43M | 61.16% | ↗ |
| 155 | 2007 | Stephen P. MacMillan President and Chief Executive Officer | 950.0K | — | 673.4K | — | 1.10M | 233.1K | 6.59M | 10.22% | ↗ |
| 156 | 2007 | Stephen Si Johnson Vice President; Group President, MedSurg | 526.3K | — | — | — | 527.7K | 117.3K | 2.56M | 0.00% | ↗ |
| 157 | 2007 | Luciano Cattani Vice President; Group President, International | 882.3K | — | — | — | 419.9K | 122.1K | 2.32M | 0.00% | ↗ |
| 158 | 2007 | Stephen P. MacMillan Chairman, President and Chief Executive Officer | 950.0K | — | — | — | 1.10M | 233.1K | 2.28M | 0.00% | ↗ |
| 159 | 2007 | James E. Kemler Vice President; Group President, Biotech, Spine, Osteosynthesis and Development | 446.7K | — | — | — | 389.7K | 93.2K | 2.19M | 0.00% | ↗ |
| 160 | 2007 | James E. Kemler Vice President; Group President, BOD | 446.7K | — | — | — | 389.7K | 93.2K | 2.19M | 0.00% | ↗ |
| 161 | 2007 | Dean H. Bergy Advisor to the Vice President and Chief Financial Officer | 400.0K | — | — | 1.20M | 356.4K | 94.5K | 2.06M | 58.60% | ↗ |
| 162 | 2007 | Dean H. Bergy Vice President and Chief Financial Officer | 400.0K | — | — | — | 356.4K | 94.5K | 1.74M | 0.00% | ↗ |
| 163 | 2006 | Stephen P. MacMillan President and Chief Executive Officer | 900.0K | — | 673.4K | — | 877.5K | 207.0K | 6.07M | 11.09% | ↗ |
| 164 | 2006 | Stephen Si Johnson Vice President; Group President, MedSurg | 498.8K | 108.0K | — | — | 287.0K | 114.8K | 2.39M | 0.00% | ↗ |
| 165 | 2006 | James E. Kemler Vice President; Group President, BOD | 423.3K | 32.2K | — | — | 287.8K | 76.8K | 2.00M | 0.00% | ↗ |
| 166 | 2006 | James E. Kemler Vice President; Group President, Biotech, Spine, Osteosynthesis and Development | 423.3K | 32.2K | — | — | 287.8K | 76.8K | 2.00M | 0.00% | ↗ |
| 167 | 2006 | Luciano Cattani Vice President; Group President, International | 781.0K | 90.1K | — | — | 161.1K | 92.2K | 1.96M | 0.00% | ↗ |
| 168 | 2006 | Dean H. Bergy Vice President and Chief Financial Officer | 355.0K | — | — | — | 312.0K | 83.4K | 1.51M | 0.00% | ↗ |
| 169 | 2005 | Stephen P. MacMillan President and Chief Executive Officer | 800.0K | 743.0K | — | — | — | 164.5K | 1.71M | 0.00% | ↗ |
| 170 | 2005 | Stephen Si Johnson Vice President; Group President, MedSurg | 466.3K | 415.0K | — | — | — | 97.0K | 978.3K | 0.00% | ↗ |
| 171 | 2005 | James R. Lawson Vice President; Group President, Global | 525.0K | 300.0K | — | — | — | 111.1K | 936.1K | 0.00% | ↗ |
| 172 | 2005 | James E. Kemler Vice President; Group President, Biotech, Spine, | 398.3K | 275.0K | — | — | — | 74.5K | 747.9K | 0.00% | ↗ |
| 173 | 2005 | Dean H. Bergy Vice President and Chief Financial Officer | 325.0K | 288.0K | — | — | — | 66.0K | 679.0K | 0.00% | ↗ |
| 174 | 2004 | Stephen P. MacMillan President and Chief Executive Officer | 608.3K | 635.0K | — | — | — | 112.6K | 1.36M | 0.00% | ↗ |
| 175 | 2004 | James R. Lawson Vice President; Group President, Global | 500.0K | 485.0K | — | — | — | 97.4K | 1.08M | 0.00% | ↗ |
| 176 | 2004 | Stephen Si Johnson Vice President; Group President, MedSurg | 441.3K | 416.0K | — | — | — | 84.3K | 941.5K | 0.00% | ↗ |
| 177 | 2004 | James E. Kemler Vice President; Group President, Biotech, Spine, | 378.3K | 275.0K | — | — | — | 61.5K | 714.8K | 0.00% | ↗ |
| 178 | 2004 | Dean H. Bergy Vice President and Chief Financial Officer | 275.0K | 275.0K | — | — | — | 57.8K | 607.8K | 0.00% | ↗ |
| 179 | 2003 | Stephen P. MacMillan President and Chief Executive Officer | 320.8K | 650.0K | 3.37M | — | — | 16.6K | 4.35M | 77.32% | ↗ |
| 180 | 2003 | James R. Lawson Vice President; Group President, Global | 475.0K | 385.0K | — | — | — | 85.3K | 945.3K | 0.00% | ↗ |
| 181 | 2003 | Stephen Si Johnson Vice President; Group President, MedSurg | 416.3K | 325.0K | — | — | — | 80.4K | 821.7K | 0.00% | ↗ |
| 182 | 2003 | James E. Kemler Vice President; Group President, Biotech, Spine, | 350.0K | 185.0K | — | — | — | 60.5K | 595.5K | 0.00% | ↗ |
| 183 | 2003 | Dean H. Bergy Vice President and Chief Financial Officer | 250.0K | 250.0K | — | — | — | 44.0K | 544.0K | 0.00% | ↗ |
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kevin A. Lobo | Chairman & CEO | 5M | male |
| Glenn S. Boehnlein | Advisor | 2M | male |
| Spencer S. Stiles | President & COO | 2M | male |
| J. Andrew Pierce | Group President of MedSurg & Neurotechnology | 2M | male |
| Preston Wells | Vice President & Chief Financial Officer | 1M | male |
| Viju S. Menon | Group President of Global Quality & Operations | 1M | male |
| Robert S. Fletcher | Vice President & Chief Legal Officer | 895.9K | male |
| William E. Berry Jr. | Vice President & Chief Accounting Officer | — | male |
| Dana S. McMahon | Vice President & Chief Compliance Officer | — | female |
| Debra S. King | VP and Chief Digital & Information Officer | — | female |
| Jason Beach | Vice President of Finance & Investor Relations | — | male |
| Robert C. Cohen | Chief Technology Officer and Vice President of Global R&D - Joint Replacement | — | male |
| Transaction Date | Disclosed | Senator | State | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2022-11-30 | 2022-12-21 | Dan Sullivan | AK | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2020-04-14 | 2020-05-08 | David Perdue | — | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2019-09-30 | 2019-11-05 | David Perdue | — | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2019-02-28 | 2019-03-18 | John Reed | RI | Self | Sale (Full) | $15,001 - $50,000 | ↗ |
| 2019-02-28 | 2019-03-18 | John Reed | RI | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2019-02-04 | 2019-03-01 | John Reed | RI | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2018-03-09 | 2018-03-12 | John Reed | RI | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2017-10-30 | 2017-11-02 | David Perdue | — | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2017-08-24 | 2017-09-12 | Sheldon Whitehouse | RI | Self | Purchase | $1,001 - $15,000 | ↗ |
| 2017-05-24 | 2017-06-06 | David Perdue | — | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2016-09-08 | 2016-10-11 | Susan M. Collins | ME | Spouse | Purchase | $50,001 - $100,000 | ↗ |
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2026-01-23 | 2026-02-20 | Thomas H. Kean | NJ07 | — | Sale | $15,001 - $50,000 | ↗ |
| 2025-12-10 | 2026-01-12 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-11-20 | 2025-12-19 | Thomas H. Kean | NJ07 | — | Sale | $15,001 - $50,000 | ↗ |
| 2025-11-18 | 2025-12-15 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-10-17 | 2025-11-18 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-10-16 | 2026-01-13 | Julia Letlow | LA05 | — | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2025-10-07 | 2025-11-14 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2025-09-12 | 2025-10-15 | Thomas H. Kean | NJ07 | — | Sale | $15,001 - $50,000 | ↗ |
| 2025-08-25 | 2025-09-19 | Thomas H. Kean | NJ07 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-07-31 | 2025-08-21 | Thomas H. Kean | NJ07 | — | Sale | $15,001 - $50,000 | ↗ |
| 2025-06-26 | 2025-07-17 | Thomas H. Kean | NJ07 | — | Sale | $15,001 - $50,000 | ↗ |
| 2025-04-08 | 2025-05-08 | Rob Bresnahan | PA08 | — | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2025-04-07 | 2025-05-12 | Jared Moskowitz | FL23 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-03-13 | 2025-04-14 | Jefferson Shreve | IN06 | — | Sale | $50,001 - $100,000 | ↗ |
| 2025-02-26 | 2025-03-14 | Thomas H. Kean | NJ07 | — | Sale | $15,001 - $50,000 | ↗ |
| 2025-01-15 | 2025-02-11 | Jared Moskowitz | FL23 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2024-10-23 | 2026-01-13 | Julia Letlow | LA05 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2024-10-14 | 2024-11-11 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2024-09-13 | 2024-10-08 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2024-03-22 | 2024-04-05 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SYK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
